Home
  >  
Section 11

EurekaMag Full Text Articles Chapter 10,039



References:

Huang, C.-Hua; Norton, L.D.rrell; Zheng, F.-Li 2001: Untitled. Soil Science Society of America Journal 65(3): 955-956
Rank, K.B.; Mildner, A.M.; Leone, J.W.; Koeplinger, K.A.; Chou, K.C.; Tomasselli, A.G.; Heinrikson, R.L.; Sharma, S.K. 2001: W206R]-procaspase 3: an inactivatable substrate for caspase 8. Protein Expression and Purification 22(2): 258-266
Dick, G.M.; Sanders, K.M. 2001: (Xeno)estrogen sensitivity of smooth muscle BK channels conferred by the regulatory beta1 subunit: a study of beta1 knockout mice. Journal of Biological Chemistry 276(48): 44835-44840
Martin, Bénédicte.; Possémé, Fçoise.; Le Barbier, C.; Carreaux, Fçois.; Carboni, B.; Seiler, N.; Moulinoux, J-Philippe.; Delcros, J-Guy. 2002: (Z)-1,4-diamino-2-butene as a vector of boron, fluorine, or iodine for cancer therapy and imaging: Synthesis and biological evaluation. Bioorganic and Medicinal Chemistry 10(9): 2863-2871
Ginzel, M., D.; Millar, J., G.; Hanks, L., M. 2003: (Z)-9-pentacosene: Contact sex pheromone of the locust borer, Megacyllene robiniae. Chemoecology 13(3): 135-141
Beltaieef, I.; Besbes, R.; Ben-Amor, F.; Amri, H.; Villieras, M.; Villieras, J. 1999: (Z)-dimethyl alpha-(bromomethyl)fumarate, an efficient intermediate for the selective synthesis of dimethyl 3-alkyl itaconates and 2-alkyl 3-carbomethoxy-gamma-lactams. Tetrahedron 55(13): 3949-3958
Wobst, B.; Farine, J.-Pierre; Ginies, C.; Semon, E.; Robert, A.; Bonnard, O.; Connetable, S.; Bordereau, C. 1999: (Z,Z,E)-3,6,8-dodecatrien-1-ol, a major component of trail-following pheromone in two sympatric termite species Reticulitermes lucifugus grassei and R. santonensis. Journal of Chemical Ecology 25(6): 1305-1318
Peggion, C.; Mossel, E.; Formaggio, F.; Crisma, M.; Kaptein, B.; Broxterman, Q.B.; Kamphuis, J.; Toniolo, C. 2000: (alphaMe)Aun: a highly lipophilic, chiral, Calpha-tetrasubstituted alpha-amino acid. Incorporation into model peptides and preferred conformation. Journal of Peptide Research: Official Journal of the American Peptide Society 55(3): 262-269
Moretto, A.; Peggion, C.; Formaggio, F.; Crisma, M.; Toniolo, C.; Piazza, C.; Kaptein, B.; Broxterman, Q.B.; Ruiz, I.; Díaz-de-Villegas, M.D.; Galvez, J.A.; Cativiela, C. 2000: (alphaMe)Nva: stereoselective syntheses and preferred conformations of selected model peptides. Journal of Peptide Research: Official Journal of the American Peptide Society 56(5): 283-297
Cheng, Q.; Oritani, T.; Horiguchi, T. 1999: (iPrO)3TiCl-induced reactions of alpha- and beta-4(20)-epoxy-5-hydroxytriacetyltaxicin I. Tetrahedron 55(41): 12099-12108
Saulquin, X.; Scotet, E.; Trautmann, L.; Peyrat, M-Alix.; Halary, F.; Bonneville, M.; Houssaint, E. 2002: +1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10. Journal of Experimental Medicine 195(3): 353-358
Hämäläinen, O.; Toivakka-Hämäläinen, S.K.; Kuronen, P. 1999: +Gz associated stenosis of the cervical spinal canal in fighter pilots. Aviation Space and Environmental Medicine 70(4): 330-334
Corvec, S.; Caroff, N.; Espaze, E.; Marraillac, J.; Reynaud, A. 2002: -11 Mutation in the ampC promoter increasing resistance to beta-lactams in a clinical Escherichia coli strain. Antimicrobial Agents and ChemoTherapy 46(10): 3265-3267
Breen, G.; Brown, J.; Maude, S.; Fox, H.; Collier, D.; Li, T.; Arranz, M.; Shaw, D.; StClair, D. 1999: -141 C Del/Ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. American Journal of Medical Genetics 88(4): 407-410
Pola, R.; Gaetani, E.; Flex, A.; Aloi, F.; Papaleo, P.; Gerardino, L.; De Martini, D.; Flore, R.; Pola, P.; Bernabei, R. 2002: -174 G/C interleukin-6 gene polymorphism and increased risk of multi-infarct dementia: A case-control study. Experimental Gerontology 37(7): 949-955
Rossi, E.; Regolisti, G.; Perazzoli, F.; Negro, A.; Davoli, S.; Nicoli, D.; Sani, C.; Casali, B. 2001: -344C/T polymorphism of CYP11B2 gene in Italian patients with idiopathic low renin hypertension. American Journal of Hypertension 14(9 Pt 1): 934-941
Reynolds, W.F.; Stegeman, C.A.; Tervaert, J.W.C. 2002: -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis. Clinical Immunology 103(2): 154-160
Li, J.; Takahashi, E.; Gunner, M.R. 2000: -deltaG(AB) and pH dependence of the electron transfer from P(+)Q(A)(-)Q(B) toP(+)Q(A)Q(B)(-) in Rhodobacter sphaeroides reaction centers. Biochemistry 39(25): 7445-7454
Beckman, J.S. 2001: -OONO: rebounding from nitric oxide. Circulation Research 89(4): 295-297
Della Rovere, F.; Granata, A.; Saija, A.; Broccio, M.; Tomaino, A.; Zirilli, A.; De Caridi, G.; Broccio, G. 2000: -SH groups and glutathione in cancer patient's blood. Anticancer Research 20(3a): 1595-1598
van Haeften, T.W.; Stumvoll, M. 2001: --to: Albareda M et al. (2000) assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 43: 1507-1511. Diabetologia 44(6): 783
Benatar, S.R. 2002: But can it solve these problems itself?. BMJ 324(7352): 1525-1526
Kroukamp, G. 2002: And a collaborative group of otorhinolaryngologists reports its findings. BMJ 325(7372): 1117
Thallmair, M. 1999: And they do grow! Nerve growth after CNS lesions. Vierteljahrsschrift der Naturforschenden Gesellschaft in Zuerich 144(1): 37-47
Glover, D.M.; Nurse, P.; Hunt, T.; Hartwell, L. 2001: ... still cycling. Journal of Cell Science 114(Pt 22): 3953-3954
Varady, R.G.; Hankins, K.B.; Kaus, A.; Young, E.; Merideth, R. 2001: To the Sea of Cortes: Nature, water, culture, and livelihood in the Lower Colorado River Basin and Delta: An overview of issues, policies, and approaches to environmental restoration. Journal of Arid Environments 49(1): 195-209
Blasig, I.E.; Giese, H.; Schroeter, M.L.; Sporbert, A.; Utepbergenov, D.I.; Buchwalow, I.B.; Neubert, K.; Schönfelder, G.; Freyer, D.; Schimke, I.; Siems, W.E.; Paul, M.; Haseloff, R.F.; Blasig, R. 2001: *NO and oxyradical metabolism in new cell lines of rat brain capillary endothelial cells forming the blood-brain barrier. Microvascular Research 62(2): 114-127
Beeck, P.; Tauber, S.; Kiel, S.; Borcherding, J. 2002: 0+ Perch predation on 0+ bream: A case study in a eutrophic gravel pit lake. Freshwater Biology 47(12): 2359-2369
Hanashi, Tomoko; Yoshida, Misao; Izumi, Yosuke; Momma, Kumiko; Kato, Hisahito; Et-Al 2001: 0-I type adenocarcinoma at the esophagogastric junction, most of which was located in the esophageal side, report of a case. Stomach and Intestine 36(5): 729-733
Bertini, L.; Tagariello, V.; Mancini, S.; Ciaschi, A.; Posteraro, C.M.; Di Benedetto, P.; Martini, O. 1999: 0.75% and 0.5% ropivacaine for axillary brachial plexus block: A clinical comparison with 0.5% bupivacaine. Regional Anesthesia and Pain Medicine 24(6): 514-518
Kappen, C.; Salbaum, J.M. 2001: 09/15: Comparative genomics of a conserved chromosomal region associated with a complex human phenotype. Genomics 73(2): 171-178
van Honk, J.; Schutter, D.J.L.G.; d'Alfonso, A.A.L.; Kessels, R.P.C.; de Haan, E.H.F. 2002: 1 Hz rTMS over the right prefrontal cortex reduces vigilant attention to unmasked but not to masked fearful faces. Biological Psychiatry 52(4): 312-317
Mollestad, K.E.; Heier, T.; Steen, P.A.; Raeder, J.C. 1998: 1 MAC-incision sevoflurane prevents explicit awareness during surgical skin incision and tracheal intubation. Acta Anaesthesiologica Scandinavica 42(10): 1184-1187
Dajani, E.Z.; Larsen, K.R.; Taylor, J.; Dajani, N.E.; Shahwan, T.G.; Neeleman, S.D.; Taylor, M.S.; Dayton, M.T.; Mir, G.N. 1999: 1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties. Journal of Pharmacology and Experimental Therapeutics 291(1): 31-38
Elix, J.; Wardlaw, J.; Archer, A. 2002: 1'-Methyl hypothamnolate, a new beta-orcinol meta-depside from a chemical race of the lichen Pertusaria tropica (Ascomycotina, Pertusariaceae). Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg 30-32: 35-40
Franco, C.D.; Vieira, Z.E. 2000: 1,001 subclavian perivascular brachial plexus blocks: Success with a nerve stimulator. Regional Anesthesia and Pain Medicine 25(1): 41-46
Rusin, O.; Kral, V. 2001: 1,1'-Binaphthyl substituted calixresorcinols-methyl red complexes: Receptors for optical saccharide sensing. Tetrahedron Letters 42(25): 4235-4238, 18 June
Lookene, A.; Zhang, L.; Tougu, V.; Olivecrona, G. 2003: 1,1'-bis(anilino)-4-,4'-bis(naphtalene)-8,8'-disulfonate acts as an inhibitor of lipoprotein lipase and competes for binding with apolipoprotein CII. Journal of Biological Chemistry 278(39): 37183-37194
Keller, D.A.; Lieder, P.H.; Brock, W.J.; Cook, J.C. 1998: 1,1,1-Trifluoro-2,2-dichloroethane (HCFC-123) and 1,1,1-trifluoro-2-bromo-2-chloroethane (halothane) cause similar biochemical effects in rats exposed by inhalation for five days. Drug and Chemical Toxicology 21(4): 405-415
Laden, F.; Collman, G.; Iwamoto, K.; Alberg, A.J.; Berkowitz, G.S.; Freudenheim, J.L.; Hankinson, S.E.; Helzlsouer, K.J.; Holford, T.R.; Huang, H.Y.; Moysich, K.B.; Tessari, J.D.; Wolff, M.S.; Zheng, T.; Hunter, D.J. 2001: 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. Journal of the National Cancer Institute 93(10): 768-776
Forkert, P.G. 1999: 1,1-Dichloroethylene-induced Clara cell damage is associated with in situ formation of the reactive epoxide. Immunohistochemical detection of its glutathione conjugate. American Journal of Respiratory Cell and Molecular Biology 20(6): 1310-1318
Jao, C.-Ling; Ko, W.-Ching 2002: 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging by protein hydrolyzates from tuna cooking juice. Fisheries Science 68(2): 430-435
Murakami, A.; Gao, G.; Omura, M.; Yano, M.; Ito, C.; Furukawa, H.; Takahashi, D.; Koshimizu, K.; Ohigashi, H. 2000: 1,1-Dimethylallylcoumarins potently suppress both lipopolysaccharide- and interferon-gamma-induced nitric oxide generation in mouse macrophage RAW 264.7 cells. Bioorganic and Medicinal Chemistry Letters 10(1): 59-62
Sachon, E.; Milcent, T.; Sagan, S.; Convert, O.; Chassaing, G.; Lavielle, S. 2002: 1,1-diphenyl-2-methylsulfinyl ethanol: A model compound to study the reactivity towards CNBr of a photoadduct of methionine on CgammaH2. Tetrahedron Letters 43(42): 7485-7489, 14 October
Ali, A.; Yin, X.; Shen, H.; Ye, Y.; Gu, X. 1999: 1,10-Phenanthroline as a complexing agent for on-line sorbent extraction/preconcentration for flow injection-flame atomic absorption spectrometry. Analytica Chimica Acta 392(2-3): 283-289
Hinschberger, A.; Gillard, A.C.; Dauphin, F.; Rault, S. 2000: 1,2,3,4,5,6-hexahydrobenzo(h)(1,6)naphthyridin-5-ones: 5-HT7 receptor affinity. Pharmacy and Pharmacology Communications 6(2): 67-71
Choi, B-Min.; Kim, H-Jin.; Oh, G-Su.; Pae, H-Ock.; Oh, H.; Jeong, S.; Kwon, T-Oh.; Kim, Y-Myeong.; Chung, H-Taeg. 2002: 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose protects rat neuronal cells (Neuro 2A) from hydrogen peroxide-mediated cell death via the induction of heme oxygenase-1. Neuroscience Letters 328(2): 185-189
Bojarski, A.J.; Mokrosz, M.J. 1999: 1,2,3,4-tetrahydroisoquinoline derivatives; lipophilicity evaluation vs. 5-HT1A receptor affinity. Die Pharmazie 54(11): 828-830
Biagi, G.; Giorgi, I.; Livi, O.; Manera, C.; Scartoni, V.; Betti, L.; Giannaccini, G.; Lucacchini, A. 1999: 1,2,3-Triazolo(4,5-d)pyridazines: Part VI. New 1-substituted-4-amino derivatives and their affinity towards A1 and A2A adenosine receptors. Farmaco 54(9): 615-623
Zawalich, W., S.; Bonnet-Eymard, M.; Malaisse, W., J. 1998: 1,2,3-tri(methylsuccinyl) glycerol ester stimulates inositol phosphate accumulation, insulin secretion and induces time-dependent potentiation of release. Research Communications in Pharmacology and Toxicology 3(1-2): 11-22
Cerecetto, H.; Gonzalez, M.; Onetto, S.; Risso, M.; Saenz, P.; Seoane, G.; Bruno, A.M.; Alarcon, J.; Olea-Azar, C.; Lopez-De-Cerain, A.; Ezpeleta, O.; Monge, A. 2001: 1,2,4-Triazine N-oxide and N,N'-dioxide derivatives: Studies as potential hypoxic cytotoxins and DNA binder. Medicinal Chemistry Research 10(5): 328-337
Mischne, M. 2003: 1,2,4-Trioxane in organic synthesis. Unusual entry to diverse carbocyclic frameworks derived from beta-ionone. Tetrahedron Letters 44(31): 5823-5826, 28 July
Bouzide, A.; Sauvé, G.; Sévigny, G.; Yelle, J. 2003: 1,2,5,6-Tetra-O-benzyl-D-mannitol derivatives as novel HIV protease inhibitors. Bioorganic and Medicinal Chemistry Letters 13(20): 3601-3605
Monge, A.; Lopez-De-Cerain, A.; Ezpeleta, O.; Cerecetto, H.; Dias, E.; Di-Maio, R.; Gonzalez, M.; Onetto, S.; Risso, M.; Seoane, G.; Zinola, F.; Olea-Azar, C. 1998: 1,2,5-Oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins: Structure-activity relationships. Pharmazie 53(10): 698-702
Boiani, M.; Cerecetto, H.; González, M.; Risso, M.; Olea-Azar, C.; Piro, O.E.; Castellano, E.E.; López de Ceráin, A.; Ezpeleta, O.; Monge-Vega, A. 2001: 1,2,5-Oxadiazole N-oxide derivatives as potential anti-cancer agents: Synthesis and biological evaluation. Part IV. European Journal of Medicinal Chemistry 36(10): 771-782
Sabb, A.L.; Vogel, R.L.; Kelly, M.G.; Palmer, Y.; Smith, D.L.; Andree, T.H.; Schechter, L.E. 2001: 1,2,5-Thiadiazole derivatives are potent and selective ligands at human 5-HT1A receptors. Bioorganic and Medicinal Chemistry Letters 11(8): 1069-1071
Groutas, W.C.; Epp, J.B.; Kuang, R.; Ruan, S.; Chong, L.S.; Venkataraman, R.; Tu, J.; He, S.; Yu, H.; Fu, Q.; Li, Y.H.; Truong, T.M.; Vu, N.T. 2001: 1,2,5-Thiadiazolidin-3-one 1,1 dioxide: a powerful scaffold for probing the S' subsites of (chymo)trypsin-like serine proteases. Archives of Biochemistry and Biophysics 385(1): 162-169
Cerecetto, H.; Di Maio, R.; González, M.; Risso, M.; Saenz, P.; Seoane, G.; Denicola, A.; Peluffo, G.; Quijano, C.; Olea-Azar, C. 1999: 1,2,5-Oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs: structure-activity relationships. Journal of Medicinal Chemistry 42(11): 1941-1950
Mráz, J.; Gálová, E.; Nohová, H.; Vitková, D. 1998: 1,2- and 1,4-cyclohexanediol: Major urinary metabolites and biomarkers of exposure to cyclohexane, cyclohexanone, and cyclohexanol in humans. International Archives of Occupational and Environmental Health 71(8): 560-565
Martinez, A.; Estevez, J., C.; Estevez, R., J.; Castedo, L. 2000: 1,2- and 1,4-naphthoquinones: General synthesis of benzo(b)naphtho(2,3-d)furan-6,11-diones. Tetrahedron Letters 41(14): 2365-2367
Wells, G.J.; Tao, M.; Josef, K.A.; Bihovsky, R. 2001: 1,2-Benzothiazine 1,1-dioxide P(2)-P(3) peptide mimetic aldehyde calpain i inhibitors. Journal of Medicinal Chemistry 44(21): 3488-3503
Finch, R.A.; Shyam, K.; Penketh, P.G.; Sartorelli, A.C. 2001: 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity. Cancer Research 61(7): 3033-3038
Younis, H.S.; Hoglen, N.C.; Kuester, R.K.; Gunawardhana, L.; Sipes, I.G. 2000: 1,2-Dichlorobenzene-mediated hepatocellular oxidative stress in Fischer-344 and Sprague-Dawley rats. Toxicology and Applied Pharmacology 163(2): 141-148
Tinker, A.C.; Beaton, H.G.; Boughton-Smith, N.; Cook, T.R.; Cooper, S.L.; Fraser-Rae, L.; Hallam, K.; Hamley, P.; McInally, T.; Nicholls, D.J.; Pimm, A.D.; Wallace, A.V. 2003: 1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo. Journal of Medicinal Chemistry 46(6): 913-916
Arutjunyan, A.V.; Kerkeshko, G.O.; Anisimov, V.N.; Stepanov, M.G.; Pozdeev, N.V. 2001: 1,2-Dimethylhydrazine disturbs circadian rhythms of biogenic amines in hypothalamus of rats. Voprosy Onkologii (St Petersburg) 47(5): 608-615
Rösner, H.; Vacun, G. 1999: 1,2-dioctanoyl-s,n-glycerol-induced activation of protein kinase C results in striking, but reversible growth cone shape changes and an accumulation of f-actin and serine 41-phosphorylated GAP-43 in the axonal process. European Journal of Cell Biology 78(10): 698-706
Zubin, E.M.; Stetsenko, D.A.; Oretskaya, T.S.; Gait, M.J. 2003: 1,2-Diol and hydrazide phosphoramidites for solid-phase synthesis and chemoselective ligation of 2'-modified oligonucleotides. Nucleosides Nucleotides and Nucleic Acids 22(5-8): 1375-1378
Olesen, C.E.M.; Mosier, J.; Martin, C.S.; Voyta, J.C.; Bronstein, I. 1998: 1,2-Dioxetane chemiluminescent detection of proteins and nucleic acids. Japanese Journal of Electrophoresis 42(4): 265-279
Shinada, T.; Ooyama, Y.; Hayashi, K.I.; Ohfune, Y. 2002: 1,2-Dioxo-3-isopropyloxy-4-methyl-3-cyclobutene as a nucleophilic synthon. Synthesis of Sq-containing cinnamic acid derivatives. Tetrahedron Letters 43(38): 6755-6758, 16 September
Yamauchi, K.; Hayashi, M.; Yamamoto, I. 1999: 1,2-dotriacontanedioyl-sn-glycero-3-phosphocholine: a cyclic lipid used for phospholipase A2-catalyzed modulation of the liposome surface charge. Journal of Biochemistry 125(5): 853-857
Tazaki, H.; Iwasaki, T.; Kawakami, Y.; Nabeta, K. 1999: 1,2-Hydride Shift in the Biosynthesis of Pinguisane-type Sesquiterpenes. Bioscience Biotechnology and Biochemistry 63(9): 1667-1668
Hauze, D.B.; Petrovskaia, O.; Taylor, B.; Joullie, M.M.; Ramotowski, R.; Cantu, A.A. 1998: 1,2-Indanediones: New reagents for visualizing the amino acid components of latent prints. Journal of Forensic Sciences 43(4): 744-747
Yenil, Nün.; Yüceer, L. 2003: 1,2-O-Trichloroethylidene acetal group protected 3,5-dieno-1,4-furanose derivatives. Carbohydrate Research 338(19): 2013-2016
Dabideen, D.; Ruan, Z.; Mootoo, D.R. 2002: 1,2-O-isopropylidene-5-alkene templates for the synthesis of oligo-tetrahydrofurans. Tetrahedron 58(11): 2077-2084, 11 March
Casarini, M.E.; Ghelfi, F.; Libertini, E.; Pagnoni, U.M.; Parsons, A.F. 2002: 1,2-Reduction of alpha,beta-unsaturated hydrazones using dimethylamine-borane/p-toluenesulfonic acid: An easy route to allyl hydrazines. Tetrahedron 58(39): 7925-7932, 23 September
Combrink, K.D.; Gülgeze, H.B.; Meanwell, N.A.; Pearce, B.C.; Zulan, P.; Bisacchi, G.S.; Roberts, D.G.; Stanley, P.; Seiler, S.M. 1998: 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase. Journal of Medicinal Chemistry 41(24): 4854-4860
Han, K.S.; Kang, H.J.; Kim, E.Y.; Yoon, W.J.; Sohn, S.; Kwon, H.J.; Gwag, B.J. 2001: 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid induces caspase-mediated apoptosis and reactive oxygen species-mediated necrosis in cultured cortical neurons. Journal of Neurochemistry 78(2): 230-239
Kim, M.S.; Sabri, M.I.; Miller, V.H.; Kayton, R.J.; Dixon, D.A.; Spencer, P.S. 2001: 1,2-diacetylbenzene, the neurotoxic metabolite of a chromogenic aromatic solvent, induces proximal axonopathy. Toxicology and Applied Pharmacology 177(2): 121-131
Herron, D.K.; Goodson, T.; Wiley, M.R.; Weir, L.C.; Kyle, J.A.; Yee, Y.K.; Tebbe, A.L.; Tinsley, J.M.; Mendel, D.; Masters, J.J.; Franciskovich, J.B.; Sawyer, J.S.; Beight, D.W.; Ratz, A.M.; Milot, G.; Hall, S.E.; Klimkowski, V.J.; Wikel, J.H.; Eastwood, B.J.; Towner, R.D.; Gifford-Moore, D.S.; Craft, T.J.; Smith, G.F. 2000: 1,2-dibenzamidobenzene inhibitors of human factor Xa. Journal of Medicinal Chemistry 43(5): 859-872
Hoglen, N.C.; Younis, H.S.; Hartley, D.P.; Gunawardhana, L.; Lantz, R.C.; Sipes, I.G. 1998: 1,2-Dichlorobenzene-induced lipid peroxidation in male Fischer 344 rats is Kupffer cell dependent. Toxicological Sciences: An Official Journal of the Society of Toxicology 46(2): 376-385
Cavallotti, Camilla; Orsini, Fulvia; Sello, Guido; Di-Gennaro, Patrizia; Galli, Enrica; Bestetti, Giuseppina 1999: 1,2-dihydro-1,2-dihydroxynaphthalene dehydrogenase containing recombinant strains: Preparation, isolation and characterisation of 1,2-dihydroxynaphthalenes and 1,2-naphthoquinones. Tetrahedron 55(14): 4467-4480
Turusov, V.; Trukhanova, L.; Samoilov, D. 2000: 1,2-Dimethylhydrazine carcinogenesis in CBA male mice prenatally treated with diethylstilbestrol. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft für Toxikologische Pathologie 52(3): 241-245
Colussi, C.; Fiumicino, S.; Giuliani, A.; Rosini, S.; Musiani, P.; Macrí, C.; Potten, C.S.; Crescenzi, M.; Bignami, M. 2001: 1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. Journal of the National Cancer Institute 93(20): 1534-1540
Viña, D.; Santana, L.; Uriarte, E. 2001: 1,2-disubstituted cyclohexane carbocyclic analogues of nucleosides. Nucleosides Nucleotides and Nucleic Acids 20(4-7): 1363-1365
Takeuchi, K.; Bastian, J.A.; Gifford-Moore, D.S.; Harper, R.W.; Miller, S.C.; Mullaney, J.T.; Sall, D.J.; Smith, G.F.; Zhang, M.; Fisher, M.J. 2000: 1,2-disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: A novel series of thrombin inhibitors. Bioorganic and Medicinal Chemistry Letters 10(20): 2347-2351
Zanoni, G.; Porta, A.; Meriggi, A.; Franzini, M.; Vidari, G. 2002: 1,2-Oxopalladation versus pi-allyl palladium route. A regioconvergent approach to a key intermediate for cyclopentanoids synthesis. New insights into the Pd(II)-catalyzed lactonization reaction. Journal of Organic Chemistry 67(17): 6064-6069
Miège; Maréchal 1999: 1,2-sn-Diacylglycerol in plant cells: Product, substrate and regulator. Plant Physiology and Biochemistry (Paris) 37(11): 795-808
Liu, R.; Xu, Y.; Farach-Carson, M.C.; Vogel, J.J.; Karin, N.J. 2000: 1,25 dihydroxyvitamin D(3) activates sphingomyelin turnover in ROS17/2.8 osteosarcoma cells without sphingolipid-induced changes in cytosolic Ca(2+). Biochemical and Biophysical Research Communications 273(1): 95-100
Adams, A.E.; Abu-Amer, Y.; Chappel, J.; Stueckle, S.; Ross, F.P.; Teitelbaum, S.L.; Suva, L.J. 1999: 1,25 Dihydroxyvitamin D3 and dexamethasone induce the cyclooxygenase 1 gene in osteoclast-supporting stromal cells. Journal of Cellular Biochemistry 74(4): 587-595
Siggelkow, H.; Schulz, H.; Kaesler, S.; Benzler, K.; Atkinson, M.J.; Hüfner, M. 1999: 1,25 Dihydroxyvitamin-D3 attenuates the confluence-dependent differences in the osteoblast characteristic proteins alkaline phosphatase, procollagen I peptide, and osteocalcin. Calcified Tissue International 64(5): 414-421
Balogh, G.; Boland, R.; de Boland, A.R. 2000: 1,25(OH)(2)-vitamin D(3) affects the subcellular distribution of protein kinase C isoenzymes in rat duodenum: influence of aging. Journal of Cellular Biochemistry 79(4): 686-694
Capiati, D.; Benassati, S.; Boland, R.L. 2002: 1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. Journal of Cellular Biochemistry 86(1): 128-135
Zhao, B.; Nemere, I. 2002: 1,25(OH)2D3-mediated phosphate uptake in isolated chick intestinal cells: effect of 24,25(OH)2D3, signal transduction activators, and age. Journal of Cellular Biochemistry 86(3): 497-508
Drissi, H.; Pouliot, A.; Koolloos, C.; Stein, J.L.; Lian, J.B.; Stein, G.S.; van Wijnen, A.é J. 2002: 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Experimental Cell Research 274(2): 323-333
Ecarot, B.; Desbarats, M. 1999: 1,25-(OH)2D3 down-regulates expression of Phex, a marker of the mature osteoblast. Endocrinology 140(3): 1192-1199
Boyan, B.D.; Sylvia, V.L.; Dean, D.D.; Pedrozo, H.; Del Toro, F.; Nemere, I.; Posner, G.H.; Schwartz, Z. 1999: 1,25-(OH)2D3 modulates growth plate chondrocytes via membrane receptor-mediated protein kinase C by a mechanism that involves changes in phospholipid metabolism and the action of arachidonic acid and PGE2. Steroids 64(1-2): 129-136
Aschenbrenner, J.K.; Sollinger, H.W.; Becker, B.N.; Hullett, D.A. 2001: 1,25-(OH(2))D(3) alters the transforming growth factor beta signaling pathway in renal tissue. Journal of Surgical Research 100(2): 171-175
Holliday, L.S.; Gluck, S.L.; Slatopolsky, E.; Brown, A.J. 2000: 1,25-Dihydroxy-19-nor-vitamin D(2), a vitamin D analog with reduced bone resorbing activity in vitro. Journal of the American Society of Nephrology: Jasn 11(10): 1857-1864
Hershberger, P.A.; Modzelewski, R.A.; Shurin, Z.R.; Rueger, R.M.; Trump, D.L.; Johnson, C.S. 1999: 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Research 59(11): 2644-2649
Braun, J.; Dinkelacker, C.; Bohnet, S.; Kreft, B.; Dalhoff, K. 1999: 1,25-Dihydroxycholecalciferol stimulates ICAM-1 expression of human alveolar macrophages in healthy controls and patients with sarcoidosis. Lung 177(3): 139-149
Cordero, J.B.; Cozzolino, M.; Lu, Y.; Vidal, M.; Slatopolsky, E.; Stahl, P.D.; Barbieri, M.A.; Dusso, A. 2002: 1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor. Journal of Biological Chemistry 277(41): 38965-38971
Stedman, L.; Nickel, K.P.; Castillo, S.S.; Andrade, J.; Burgess, J.R.; Teegarden, D. 2003: 1,25-dihydroxyvitamin D inhibits vitamin e succinate-induced apoptosis in C3H10T1/2 cells but not Harvey ras-transfected cells. Nutrition and Cancer 45(1): 93-100
Itonaga, I.; Sabokbar, A.; Neale, S.D.; Athanasou, N.A. 1999: 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. Biochemical and Biophysical Research Communications 264(2): 590-595
Sung, V.; Feldman, D. 2000: 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration. Molecular and Cellular Endocrinology 164(1-2): 133-143
Krüger, S.; Kreft, B. 2001: 1,25-dihydroxyvitamin D3 differentially regulates IL-1alpha-stimulated IL-8 and MCP-1 mRNA expression and chemokine secretion by human primary proximal tubular epithelial cells. Experimental Nephrology 9(3): 223-228
Menaa, C.; Barsony, J.; Reddy, S.V.; Cornish, J.; Cundy, T.; Roodman, G.D. 2000: 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 15(2): 228-236
Takahashi, H.; Ibe, M.; Honma, M.; Ishida-Yamamoto, A.; Hashimoto, Y.; Iizuka, H. 2003: 1,25-dihydroxyvitamin D(3) increases human cystatin a expression by inhibiting the Raf-1/MEK1/ERK signaling pathway of keratinocytes. Archives of Dermatological Research 295(2): 80-87
Li, X.Y.; Boudjelal, M.; Xiao, J.H.; Peng, Z.H.; Asuru, A.; Kang, S.; Fisher, G.J.; Voorhees, J.J. 1999: 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Molecular Endocrinology 13(10): 1686-1694
Sanchez, Bña.; Lopez-Martin, E.; Segura, C.; Labandeira-Garcia, J.L.; Perez-Fernandez, R. 2002: 1,25-Dihydroxyvitamin D(3) increases striatal GDNF mRNA and protein expression in adult rats. Brain Research. Molecular Brain Research 108(1-2): 143-146
Garach-Jehoshua, O.; Ravid, A.; Liberman, U.A.; Koren, R. 1999: 1,25-Dihydroxyvitamin D3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes. Endocrinology 140(2): 713-721
Merchiers, P.; Bulens, F.; Stockmans, I.; De Vriese, A.; Convents, R.; Bouillon, R.; Collen, D.; Belayew, A.; Carmeliet, G. 1999: 1,25-Dihydroxyvitamin D(3) induction of the tissue-type plasminogen activator gene is mediated through its multihormone-responsive enhancer. FEBS Letters 460(2): 289-296
Berer, A.; Stöckl, J.; Majdic, O.; Wagner, T.; Kollars, M.; Lechner, K.; Geissler, K.; Oehler, L. 2000: 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Experimental Hematology 28(5): 575-583
De Haes, P.; Garmyn, M.; Degreef, H.; Vantieghem, K.; Bouillon, R.; Segaert, S. 2003: 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. Journal of Cellular Biochemistry 89(4): 663-673
Riachy, R.; Vandewalle, B.; Kerr Conte, J.; Moerman, E.; Sacchetti, P.; Lukowiak, B.; Gmyr, V.; Bouckenooghe, T.; Dubois, M.; Pattou, Fçois. 2002: 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology 143(12): 4809-4819
Rajasree, S.; Umashankar, P.R.; Lal, A.V.; Sarma, P.Sankara.; Kartha, C.C. 2002: 1,25-dihydroxyvitamin D3 receptor is upregulated in aortic smooth muscle cells during hypervitaminosis D. Life Sciences 70(15): 1777-1788
Rivera-Bermúdez, Més.A.; Bertics, P.J.; Albrecht, R.M.; Mosavin, R.; Mellon, W.S. 2002: 1,25-Dihydroxyvitamin D3 selectively translocates PKCalpha to nuclei in ROS 17/2.8 cells. Molecular and Cellular Endocrinology 188(1-2): 227-239
Chen, A.; Davis, B.H.; Bissonnette, M.; Scaglione-Sewell, B.; Brasitus, T.A. 1999: 1,25-Dihydroxyvitamin D(3) stimulates activator protein-1-dependent Caco-2 cell differentiation. Journal of Biological Chemistry 274(50): 35505-35513
Weinreich, T.; Landolt, M.; Booy, C.; Wüthrich, R.; Binswanger, U. 1999: 1,25-dihydroxyvitamin D3 stimulates transforming growth factor-beta1 synthesis by mouse renal proximal tubular cells. Kidney and Blood Pressure Research 22(3): 99-105
Nashold, F.E.; Miller, D.J.; Hayes, C.E. 2000: 1,25-Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 103(2): 171-179
Bollinger Bollag, W.; Bollag, R.J. 2001: 1,25-Dihydroxyvitamin D(3), phospholipase D and protein kinase C in keratinocyte differentiation. Molecular and Cellular Endocrinology 177(1-2): 173-182
Van Abel, M.; Hoenderop, J.G.J.; Dardenne, O.; St Arnaud, Ré.; Van Os, C.H.; Van Leeuwen, H.J.P.T.M.; Bindels, Ré.J.M. 2002: 1,25-dihydroxyvitamin D(3)-independent stimulatory effect of estrogen on the expression of ECaC1 in the kidney. Journal of the American Society of Nephrology: Jasn 13(8): 2102-2109
Dranitzki-Elhalel, M.; Wald, H.; Popovtzer, M.M.; Sprague, S.M. 1999: 1,25-Dihydroxyvitamin D3-induced calcium efflux from calvaria is mediated by protein kinase C. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 14(11): 1822-1827
Gaschott, T.; Wächtershäuser, A.; Steinhilber, D.; Stein, J. 2001: 1,25-Dihydroxycholecalciferol enhances butyrate-induced p21(Waf1/Cip1) expression. Biochemical and Biophysical Research Communications 283(1): 80-85
Van Etten, E.; Decallonne, B.; Mathieu, C. 2002: 1,25-dihydroxycholecalciferol: endocrinology meets the immune system. Proceedings of the Nutrition Society 61(3): 375-380
Reinhardt, T.A.; Koszewski, N.J.; Omdahl, J.; Horst, R.L. 1999: 1,25-Dihydroxyvitamin D(3) and 9-cis-retinoids are synergistic regulators of 24-hydroxylase activity in the rat and 1, 25-dihydroxyvitamin D(3) alters retinoic acid metabolism in vivo. Archives of Biochemistry and Biophysics 368(2): 244-248
Wang, Q.; Yang, W.; Uytingco, M.S.; Christakos, S.; Wieder, R. 2000: 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Research 60(7): 2040-2048
Wang, Q.; Lee, D.; Sysounthone, V.; Chandraratna RAS; Christakos, S.; Korah, R.; Wieder, R. 2001: 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects. Breast Cancer Research and Treatment 67(2): 157-168
Endo, K.; Katsumata, K.; Hirata, M.; Masaki, T.; Kubodera, N.; Nakamura, T.; Ikeda, K.; Ogata, E. 2000: 1,25-dihydroxyvitamin D3 as well as its analogue OCT lower blood calcium through inhibition of bone resorption in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 15(1): 175-181
Pourgholami, M.H.; Akhter, J.; Finlay, I.G.; Morris, D.L. 2000: 1,25-dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferative effect in the human hepatoblastoma cell line HepG2. Anticancer Research 20(2a): 723-727
Ravid, A.; Rocker, D.; Machlenkin, A.; Rotem, C.; Hochman, A.; Kessler-Icekson, G.; Liberman, U.A.; Koren, R. 1999: 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Research 59(4): 862-867
Muto, A.; Kizaki, M.; Yamato, K.; Kawai, Y.; Kamata-Matsushita, M.; Ueno, H.; Ohguchi, M.; Nishihara, T.; Koeffler, H.P.; Ikeda, Y. 1999: 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1). Blood 93(7): 2225-2233
Staeva-Vieira, T.P.; Freedman, L.P. 2002: 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. Journal of Immunology 168(3): 1181-1189
Karmali, R.; Nijs-De Wolf, N.; Beyer, I.; Hendy, G.N.; Bergmann, P. 1999: 1,25-dihydroxyvitamin D3 inhibits parathyroid hormone-related peptide mRNA expression in fetal rat long bones in culture. In Vitro Cellular and Developmental Biology. Animal 35(5): 296-298
Varga, F.; Spitzer, S.; Rumpler, M.; Klaushofer, K. 2003: 1,25-Dihydroxyvitamin D3 inhibits thyroid hormone-induced osteocalcin expression in mouse osteoblast-like cells via a thyroid hormone response element. Journal of Molecular Endocrinology 30(1): 49-57
Yamamoto, T.; Kozawa, O.; Tanabe, K.; Akamatsu, S.; Matsuno, H.; Dohi, S.; Hirose, H.; Uematsu, T. 2002: 1,25-dihydroxyvitamin D3 stimulates vascular endothelial growth factor release in aortic smooth muscle cells: role of p38 mitogen-activated protein kinase. Archives of Biochemistry and Biophysics 398(1): 1-6
Kaneko, A.; Suzuki, S.; Hara, M.; Mori, J.; Kumagai, M.; Yajima, H.; Yamashita, K.; Kakizawa, T.; Yamazaki, M.; Takeda, T.; Miyamoto, T.; Ichikawa, K.; Hashizume, K. 1999: 1,25-Dihydroxyvitamin D3 suppresses the expression of the VCAM-1 receptor, VLA-4 in human leukemic HL-60 cells. Biochemical and Biophysical Research Communications 255(2): 371-376
Evans, S.R.; Shchepotin, E.I.; Young, H.; Rochon, J.; Uskokovic, M.; Shchepotin, I.B. 2000: 1,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine-induced colon carcinogenesis model. International Journal of Oncology 16(6): 1249-1254
Wagner, N.; Wagner, K-Dietrich.; Schley, G.; Badiali, L.; Theres, H.; Scholz, H. 2003: 1,25-dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and Bax. Experimental Eye Research 77(1): 1-9
Harrison, L.E.; Wang, Q.M.; Studzinski, G.P. 1999: 1,25-dihydroxyvitamin D(3)-induced retardation of the G(2)/M traverse is associated with decreased levels of p34(cdc2) in HL60 cells. Journal of Cellular Biochemistry 75(2): 226-234
Willoughby, C.A.; Rosauer, K.G.; Hale, J.J.; Budhu, R.J.; Mills, S.G.; Chapman, K.T.; MacCoss, M.; Malkowitz, L.; Springer, M.S.; Gould, S.L.; DeMartino, J.A.; Siciliano, S.J.; Cascieri, M.A.; Carella, A.; Carver, G.; Holmes, K.; Schleif, W.A.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.; Emini, E.A. 2003: 1,3,4 trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chains. Bioorganic and Medicinal Chemistry Letters 13(3): 427-431
Kilburn, J.P.; Lau, J.; Jones, R.C.F. 2001: 1,3,4-Oxadiazole formation; a novel solid support strategy. Tetrahedron Letters 42(13): 2583-2586, 26 March
Hale, J.J.; Budhu, R.J.; Mills, S.G.; Maccoss, M.; Malkowitz, L.; Siciliano, S.; Gould, S.L.; Demartino, J.A.; Springer, M.S. 2001: 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: Discovery of the pyrrolidine scaffold and determination of its stereochemical requirements. Bioorganic and Medicinal Chemistry Letters 11(11): 1437-1440
Hale, J.J.; Budhu, R.J.; Mills, S.G.; MacCoss, M.; Gould, S.L.; DeMartino, J.A.; Springer, M.S.; Siciliano, S.J.; Malkowitz, L.; Schleif, W.A.; Hazuda, D.; Miller, M.; Kessler, J.; Danzeisen, R.; Holmes, K.; Lineberger, J.; Carella, A.; Carver, G.; Emini, E.A. 2002: 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: Polar functionality and its effect on anti-HIV-1 activity. Bioorganic and Medicinal Chemistry Letters 12(20): 2997-3000
Lynch, C.L.; Hale, J.J.; Budhu, R.J.; Gentry, A.L.; Mills, S.G.; Chapman, K.T.; MacCoss, M.; Malkowitz, L.; Springer, M.S.; Gould, S.L.; DeMartino, J.A.; Siciliano, S.J.; Cascieri, M.A.; Carella, A.; Carver, G.; Holmes, K.; Schleif, W.A.; Danzeisen, R.; Hazuda, D.; Kessler, J.; Lineberger, J.; Miller, M.; Emini, E.A. 2002: 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV. Bioorganic and Medicinal Chemistry Letters 12(20): 3001-3004
Lynch, C.L.; Willoughby, C.A.; Hale, J.J.; Holson, E.J.; Budhu, R.J.; Gentry, A.L.; Rosauer, K.G.; Caldwell, C.G.; Chen, P.; Mills, S.G.; Maccoss, M.; Berk, S.; Chen, L.; Chapman, K.T.; Malkowitz, L.; Springer, M.S.; Gould, S. 2003: 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists: Modifications of the arylpropylpiperidine side chains. Bioorganic and Medicinal Chemistry Letters 13(1): 119-123, 6 January
Hale, J.J.; Budhu, R.J.; Holson, E.B.; Finke, P.E.; Oates, B.; Mills, S.G.; MacCoss, M.; Gould, S.L.; DeMartino, J.A.; Springer, M.S.; Siciliano, S.; Malkowitz, L.; Schleif, W.A.; Hazuda, D.; Miller, M.; Kessler, J.; Danzeisen, R.; Holmes, K.; Lineberger, J.; Carella, A.; Carver, G.; Emini, E. 2001: 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: Lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity. Bioorganic and Medicinal Chemistry Letters 11(20): 2741-2745
Estep, K.G.; Josef, K.A.; Bacon, E.R.; Illig, C.R.; Toner, J.L.; Mishra, D.; Blazak, W.F.; Miller, D.M.; Johnson, D.K.; Allen, J.M.; Spencer, A.; Wilson, S.A. 2000: 1,3,5-Trialkyl-2,4,6-triiodobenzenes: novel X-ray contrast agents for gastrointestinal imaging. Journal of Medicinal Chemistry 43(10): 1940-1948
Porter, R.A.; Chan, W.N.; Coulton, S.; Johns, A.; Hadley, M.S.; Widdowson, K.; Jerman, J.C.; Brough, S.J.; Coldwell, M.; Smart, D.; Jewitt, F.; Jeffrey, P.; Austin, N. 2001: 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor. Bioorganic and Medicinal Chemistry Letters 11(14): 1907-1910
Dakternieks, D.; Kuan, F.-Sheen; Duthie, A.; Tiekink, E., R.T. 2003: 1,3-Bis((trimethylsilylmethyl)dichlorostannyl)propane, ((Me3SiCH2)Cl2Sn)2(CH2)3. Applied Organometallic Chemistry 17(1): 73
Rice, J.M.; Boffetta, P. 2001: 1,3-Butadiene, isoprene and chloroprene: Reviews by the IARC monographs programme, outstanding issues, and research priorities in epidemiology. Chemico-Biological Interactions 135-136: 11-26
Conti, D.; Rodriguez, M.; Sega, A.; Taddei, M. 2003: 1,3-Cycloaddition of nitrile oxides in ionic liquids. An easier route to 3-carboxy isoxazolines, potential constrained glutamic acid analogues. Tetrahedron Letters 44(28): 5327-5330, 7 July
Garcia Ruano, J.L.; Fraile, A.; Martin, M.R.sario 1999: 1,3-Cycloaddition of nitrile oxides to cyclic and open-chain 4-oxo-2-sulfinylbut-2-enoic acid derivatives. Tetrahedron 55(50): 14491-14500
Sui, Z.; Guan, J.; Ferro, M.P.; Mccoy, K.; Wachter, M.P.; Murray, W.V.; Singer, M.; Steber, M.; Ritchie, D.M.; Argentieri, D.C. 2000: 1,3-Diarylcycloalkanopyrazoles and diphenyl hydrazides as selective inhibitors of cyclooxygenase-2. Bioorganic and Medicinal Chemistry Letters 10(6): 601-604
Phelka, A.D.; Beck, M.J.; Philbert, M.A. 2003: 1,3-Dinitrobenzene inhibits mitochondrial complex Ii in rat and mouse brainstem and cortical astrocytes. Neurotoxicology 24(3): 403-415
Reeve, I.T.; Voss, J.C.; Miller, M.G. 2002: 1,3-Dinitrobenzene metabolism and GSH depletion. Chemical Research in Toxicology 15(3): 361-366
Reeve, I.T.; Miller, M.G. 2002: 1,3-Dinitrobenzene metabolism and protein binding. Chemical Research in Toxicology 15(3): 352-360
Brasili, L.; Sorbi, C.; Franchini, S.; Manicardi, M.; Angeli, P.; Marucci, G.; Leonardi, A.; Poggesi, E. 2003: 1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists. Journal of Medicinal Chemistry 46(8): 1504-1511
Rathelot, P.; Azas, N.; El-Kashef, H.; Delmas, F.; Di Giorgio, C.; Timon-David, P.; Maldonado, Jé.; Vanelle, P. 2002: 1,3-Diphenylpyrazoles: Synthesis and antiparasitic activities of azomethine derivatives. European Journal of Medicinal Chemistry 37(8): 671-679
Hwang, S.-Hee; Kurth, M., J. 2002: 1,3-Dipolar cycloaddition of nitrile oxides to 1-phenylsulfonyl-1,3-butadienes: Synthesis of 3-(4,5-dihydroisoxazol-5-yl)pyrroles. Tetrahedron Letters 43(1): 53-56
Liu, J.-Tao; Jin, Q.-Hui; Lu, H.-Jun; Huang, W.-Yuan 2001: 1,3-Dipolar cycloaddition reactions of ethyl 2-hydropoly(per)fluoroalk-2-enoates with nitrones. Tetrahedron Letters 42(34): 5937-5939
Nemeth, A.; Kupcsulik, B.; Sevella, B. 2003: 1,3-Propanediol oxidoreductase production with Klebsiella pneumoniae DSM2026. World Journal of Microbiology and Biotechnology 19(7): 659-663
Suzuki, T.; Inui, M.; Hosokawa, S.; Kobayashi, S. 2003: 1,3-Rearrangement of ketene-N,O-acetals. Tetrahedron Letters 44(18): 3713-3716, 28 April
Haftendorn, R.; Schwarze, G.; Ulbrich-Hofmann, R. 2000: 1,3-Diacylglycero-2-phosphocholines--synthesis, aggregation behaviour and properties as inhibitors of phospholipase D. Chemistry and Physics of Lipids 104(1): 57-66
Jacobson, K.A.; Ijzerman, A.P.; Linden, J. 1999: 1,3-dialkylxanthine derivatives having high potency as antagonists at human A2B adenosine receptors. Drug Development Research 47(1): 45-53
Portevin, B.; Tordjman, C.; Pastoureau, P.; Bonnet, J.; De Nanteuil G 2000: 1,3-Diaryl-4,5,6,7-tetrahydro-2H-isoindole derivatives: a new series of potent and selective COX-2 inhibitors in which a sulfonyl group is not a structural requisite. Journal of Medicinal Chemistry 43(24): 4582-4593
Marquette, C.A.; Blum, L.J. 2003: 1,3-dichloro-5,5-dimethylhydantoin as triggering reagent for chemiluminescent biochip based on the luminol-H2O2 reaction. Analytical Letters 36(9): 1697-1706
Rogerson, Frank, S.S.; Azevedo, Zelia; Fortunato, Nelia; De-Freitas, Victor, A.P. 2002: 1,3-dimethoxybenzene, a newly identified component of port wine. Journal of the Science of Food and Agriculture 82(11): 1287-1292, 1 September
Jeong, S-Joon.; Inagaki, M.; Higuchi, R.; Miyamoto, T.; Ono, M.; Kuwano, M.; Van Soest, R.W.M. 2003: 1,3-dimethylisoguaninium, an antiangiogenic purine analog from the sponge Amphimedon paraviridis. Chemical and Pharmaceutical Bulletin 51(6): 731-733
Bryant, M.D.; Flick, K.E.; Koduri, R.S.; Wilton, D.C.; Stoddard, B.L.; Gelb, M.H. 1999: 1,3-Dioxane-4,6-dione-5-carboxamide-based inhibitors of human group IIA phospholipase A: X-ray structure of the complex and interfacial selection of inhibitors from a structural library. Bioorganic and Medicinal Chemistry Letters 9(8): 1097-1102
Murakami, Y.; Hara, H.; Okada, T.; Hashizume, H.; Kii, M.; Ishihara, Y.; Ishikawa, M.; Shimamura, M.; Mihara, S.; Kato, G.; Hanasaki, K.; Hagishita, S.; Fujimoto, M. 1999: 1,3-Disubstituted benzazepines as novel, potent, selective neuropeptide y Y1 receptor antagonists. Journal of Medicinal Chemistry 42(14): 2621-2632
Haesslein, J.L.; Baholet, I.; Fortin, M.; Iltis, A.; Khider, J.; Periers, A.M.; Pierre, C.; Vevert, J.P. 2000: 1,3-disubstituted-2-carboxy quinolones: Highly potent and selective endothelin A receptor antagonists. Bioorganic and Medicinal Chemistry Letters 10(13): 1487-1490
Suchy, M.; Kutschy, P.; Dzurilla, M.; Kovacik, V.; Andreani, A.; Alfoldi, J. 2001: 1,3-thiazino(6,5-b)indol-4-one derivatives. The first synthesis of indole phytoalexin cyclobrassinon. Tetrahedron Letters 42(39): 6961-6963
Kavakli, C.; Ozvatan, N.; Tuncel, S.A.; Salih, B. 2002: 1,4,8,11-Tetraazacyclotetradecane bound to poly(p-chloromethylstyrene-ethylene glycol dimethacrylate) microbeads for selective gold uptake. Analytica Chimica Acta 464(2): 313-322
Hailes, H.C.; Isaac, B.; Javaid, M.H.shim 2001: 1,4-Addition of chiral 2-propenylphosphonamide anions to alpha-substituted cyclopentenones: Use in enantioselective syntheses of methyl dihydrojasmonates and methyl jasmonates. Tetrahedron Letters 42(41): 7325-7328, 8 October
Perchellet, E.M.; Magill, M.J.; Huang, X.; Dalke, D.M.; Hua, D.H.; Perchellet, J.P. 2000: 1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro. Anti-Cancer Drugs 11(5): 339-352
Sherrill, R.G.; Berman, J.M.; Birkemo, L.; Croom, D.K.; Dezube, M.; Ervin, G.N.; Grizzle, M.K.; James, M.K.; Johnson, M.F.; Queen, K.L.; Rimele, T.J.; Vanmiddlesworth, F.; Sugg, E.E. 2001: 1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists. Bioorganic and Medicinal Chemistry Letters 11(9): 1145-1148
Akileswaran, L.; Brock, B.J.; Cereghino, J.L.; Gold, M.H. 1999: 1,4-benzoquinone reductase from Phanerochaete chrysosporium: cDNA cloning and regulation of expression. Applied and Environmental Microbiology 65(2): 415-421
Macchiarulo, A.; Costantino, G.; Fringuelli, D.; Vecchiarelli, A.; Schiaffella, F.; Fringuelli, R. 2002: 1,4-Benzothiazine and 1,4-benzoxazine imidazole derivatives with antifungal activity: a docking study. Bioorganic and Medicinal Chemistry 10(11): 3415-3423
Di Donato, P.; Napolitano, A. 2003: 1,4-Benzothiazines as key intermediates in the biosynthesis of red hair pigment pheomelanins. Pigment Cell Research 16(5): 532-539
Wattanasin, S.; Albert, R.; Ehrhardt, C.; Roche, D.; Sabio, M.; Hommel, U.; Welzenbach, K.; Weitz-Schmidt, G. 2003: 1,4-Diazepane-2-ones as novel inhibitors of LFA-1. Bioorganic and Medicinal Chemistry Letters 13(3): 499-502
Foster, A.; Wu, H.; Chen, W.; Williams, W.; Bowen, W.D.; Matsumoto, R.R.; Coop, A. 2003: 1,4-Dibenzylpiperazines possess anticocaine activity. Bioorganic and Medicinal Chemistry Letters 13(4): 749-751
Napoli, C.; Salomone, S.; Godfraind, T.; Palinski, W.; Capuzzi, D.M.; Palumbo, G.; D'Armiento, F.P.; Donzelli, R.; de Nigris, F.; Capizzi, R.L.; Mancini, M.; Gonnella, J.S.; Bianchi, A. 1999: 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats. Stroke 30(9): 1907-1915
Putkonen, T.; Valkonen, E.; Tolvanen, A.; Jokela, R. 2002: 1,4-Dihydropyridine equivalents: A novel approach to 2,6-dicyanopiperidine derivatives. Tetrahedron 58(39): 7869-7873, 23 September
Triggle, D.J. 2003: 1,4-Dihydropyridines as calcium channel ligands and privileged structures. Cellular and Molecular Neurobiology 23(3): 293-303
Svinka, N. 2000: 1,4-Dihydropyridines: Effects on cation transport in frog skeletal muscle. Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences 54(1-2): 40-45
Morita, T.; Hayashi, M. 1998: 1,4-Dioxane is not mutagenic in five in vitro assays and mouse peripheral blood micronucleus assay, but is in mouse liver micronucleus assay. Environmental and Molecular Mutagenesis 32(3): 269-280
Lee, J.Y.; Park, Y.K.; Seo, S.H.; So, I.S.; Chung, H.K.; Yang, B.S.; Lee, S.J.; Park, H.; Lee, Y.S. 2001: 1,4-Dioxane-fused 4-anilinoquinazoline as inhibitors of epidermal growth factor receptor kinase. Archiv der Pharmazie (Weinheim) 334(11): 357-360
Heerding, D.A.; Chan, G.; DeWolf, W.E.; Fosberry, A.P.; Janson, C.A.; Jaworski, D.D.; McManus, E.; Miller, W.H.; Moore, T.D.; Payne, D.J.; Qiu, X.; Rittenhouse, S.F.; Slater-Radosti, C.; Smith, W.; Takata, D.T.; Vaidya, K.S.; Yuan, C.C.; Huffman, W.F. 2001: 1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI). Bioorganic and Medicinal Chemistry Letters 11(16): 2061-2065
Marcaccini, S.; Miguel, D.; Torroba, Tás.; García-Valverde, Mía. 2003: 1,4-Thiazepines, 1,4-benzothiazepin-5-ones, and 1,4-benzothioxepin orthoamides via multicomponent reactions of isocyanides. Journal of Organic Chemistry 68(8): 3315-3318
Ito, H.; Sato, A.; Kusanagi, T.; Taguchi, T. 1999: 1,4-addition reaction of gamma,gamma-dialkoxyallylic zirconium species as a gem-dialkoxycyclopropyl anion equivalent. Tetrahedron Letters 40(17): 3397-3398
Imrei, Zán.; Tóth, Mós.; Tolasch, T.; Francke, W. 2002: 1,4-benzoquinone attracts males of Rhizotrogus vernus Germ. Zeitschrift für Naturforschung. C Journal of Biosciences 57(1-2): 177-181
Fringuelli, R.; Schiaffella, F.; Utrilla Navarro, M.Pilar.; Milanese, L.; Santini, C.; Rapucci, M.; Marchetti, C.; Riccardi, C. 2003: 1,4-benzothiazine analogues and apoptosis: Structure-activity relationship. Bioorganic and Medicinal Chemistry 11(15): 3245-3254
Triggle, D.J. 2003: 1,4-dihydropyridine calcium channel ligands: Selectivity of action. The roles of pharmacokinetics, state-dependent interactions, channel isoforms, and other factors. Drug Development Research 58(1): 5-17
Ahrén, B.; Holst, J.J.; Yu, S. 2000: 1,5-Anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice. European Journal of Pharmacology 397(1): 219-225
Andersen, S.M.; Lundt, I.; Marcussen, J. 2000: 1,5-Anhydro-D-fructose: Stereoselective conversions to 1,5-anhydroalditols and deoxy/amino substituted analogues. Journal of Carbohydrate Chemistry 19(6): 717-725
Andersen, Søren.M.; Lundt, I.; Marcussen, J.; Yu, S. 2002: 1,5-Anhydro-D-fructose; a versatile chiral building block: Biochemistry and chemistry. Carbohydrate Research 337(10): 873-890
D.B.accio, M.; Grossi, G.; Roma, G.; Vargiu, L.; Mura, M.; Marongiu, M.E.ena 2001: 1,5-Benzodiazepines. Part XII. Synthesis and biological evaluation of tricyclic and tetracyclic 1,5-benzodiazepine derivatives as nevirapine analogues. European Journal of Medicinal Chemistry 36(11-12): 935-949
Haider, N.; Sotelo, E. 2002: 1,5-Dimethyl-6H-pyridazino(4,5-b)carbazole, a 3-aza bioisoster of the antitumor alkaloid olivacine. Chemical and Pharmaceutical Bulletin (Tokyo) 50(11): 1479-1483
Shiga, Y.; Kametani, S.; Kadokura, T.; Akanuma, H. 1999: 1,5-Anhydroglucitol promotes glycogenolysis in Escherichia coli. Journal of Biochemistry 125(1): 166-172
Slanina, J.; Paulova, H.; Humpa, O.; Bochorakova, H.; Taborska, E. 1999: 1,5-dicaffeoylquinic acid, an antioxidant component of Cynara cardunculus leaves. Scripta Medica 72(1): 9-18
Hung, S.C.; Wang, C.C.; Chang, S.W.; Chen, C.S. 2001: 1,6-Anhydro-beta-L-hexopyranoses as valuable building blocks toward the synthesis of L-gulosamine and L-altrose derivatives. Tetrahedron Letters 42(7): 1321-1324, 12 February
Ukita, T.; Nakamura, Y.; Kubo, A.; Yamamoto, Y.; Moritani, Y.; Saruta, K.; Higashijima, T.; Kotera, J.; Fujishige, K.; Takagi, M.; Kikkawa, K.; Omori, K. 2003: 1,7- and 2,7-naphthyridine derivatives as potent and highly specific PDE5 inhibitors. Bioorganic and Medicinal Chemistry Letters 13(14): 2341-2345
Ley, S.V.; Cox, L.R.; Middleton, B.; Worrall, J.M. 1999: 1,7-Induction of chirality in Mukaiyama aldol reactions using pi-allyltricarbonyliron lactone and lactam complexes as chiral templates. Tetrahedron 55(12): 3515-3530
Santos, F.A.; Silva, R.M.; Tomé, A.R.; Rao, V.S.; Pompeu, M.M.; Teixeira, M.J.; De Freitas, L.A.; De Souza, V.L. 2001: 1,8-cineole protects against liver failure in an in-vivo murine model of endotoxemic shock. Journal of Pharmacy and Pharmacology 53(4): 505-511
Lee, J-Kul.; Jung, H-Moo.; Kim, S-Yong. 2003: 1,8-dihydroxynaphthalene (DHN)-melanin biosynthesis inhibitors increase erythritol production in Torula corallina, and DHN-melanin inhibits erythrose reductase. Applied and Environmental Microbiology 69(6): 3427-3434
Hayallah, A.M.; Sandoval-Ramírez, J.ús.; Reith, U.; Schobert, U.; Preiss, B.; Schumacher, B.; Daly, J.W.; Müller, C.E. 2002: 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists. Journal of Medicinal Chemistry 45(7): 1500-1510
Santos, F.A.; Rao, V.S. 2001: 1,8-cineol, a food flavoring agent, prevents ethanol-induced gastric injury in rats. Digestive Diseases and Sciences 46(2): 331-337
Christensen, C.; Eldrup, A..B.; Haaima, G.; Nielsen, P.E. 2002: 1,8-naphthyridin-2,7-(1,8H)-dione is an effective mimic of protonated cytosine in peptide nucleic acid triplex recognition systems. Bioorganic and Medicinal Chemistry Letters 12(21): 3121-3124
Saparbaev, M.; Langouët, S.; Privezentzev, C.V.; Guengerich, F.P.; Cai, H.; Elder, R.H.; Laval, J. 2002: 1,N(2)-ethenoguanine, a mutagenic DNA adduct, is a primary substrate of Escherichia coli mismatch-specific uracil-DNA glycosylase and human alkylpurine-DNA-N-glycosylase. Journal of Biological Chemistry 277(30): 26987-26993
Penn, A.; Nath, R.; Pan, J.; Chen, L.; Widmer, K.; Henk, W.; Chung, F.L. 2001: 1,N(2)-propanodeoxyguanosine adduct formation in aortic DNA following inhalation of acrolein. Environmental Health Perspectives 109(3): 219-224
Vinh, T.K.; Yee, S.W.; Kirby, A.J.; Nicholls, P.J.; Simons, C. 2001: 1-((Benzofuran-2-yl)phenylmethyl)triazoles as steroidogenic inhibitors: Synthesis and in vitro inhibition of human placental CYP19 aromatase. Anti-Cancer Drug Design 16(4-5): 217-225
Salerno, L.; Sorrenti, V.; Guerrera, F.; Sarva, M.C.; Siracusa, M.A.; Di-Giacomo, C.; Vanella, A. 1999: 1-((aryloxy)alkyl)-1H-imidazoles as inhibitors of neuronal nitric oxide synthase. Pharmacy and Pharmacology Communications 5(8): 491-494
Pruus, K.; Rudisaar, R.; Vaarmann, A.; Matto, V.; Allikmets, L. 2002: 1-(1-naphthyl)-piperazine, a mixed 5-HT1A and 5-HT2A/2C receptor ligand, elicits an anxiolytic-like effect in the open-field test without changes in 5-HT metabolism. Methods and Findings in Experimental and Clinical Pharmacology 24(3): 151-157
De León, E.J.; Alcaraz, M.J.; Dominguez, J.N.; Charris, J.; Terencio, M.C. 2003: 1-(2,3,4-trimethoxyphenyl)-3-(3-(2-chloroquinolinyl))-2-propen-1-one, a chalcone derivative with analgesic, anti-inflammatory and immunomodulatory properties. Inflammation Research: Official Journal of the European Histamine Research Society . 52(6): 246-257
Schertl, S.; Hartmann, R.W.; Batzl-Hartmann, C.; Schlemmer, R.; Spruss, T.; Bernhardt, G.; Gust, R.; Schönenberger, H. 2001: 1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties. Archiv der Pharmazie 334(4): 125-137
Azuma, A.; Matsuda, A.; Sasaki, T.; Fukushima, M. 2001: 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of action. Nucleosides Nucleotides and Nucleic Acids 20(4-7): 609-619
Carling, R.W.; Moore, K.W.; Moyes, C.R.; Jones, E.A.; Bonner, K.; Emms, F.; Marwood, R.; Patel, S.; Patel, S.; Fletcher, A.E.; Beer, M.; Sohal, B.; Pike, A.; Leeson, P.D. 1999: 1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1, 3-dihydroimidazol-2-one: a selective high-affinity antagonist for the human dopamine D(4) receptor with excellent selectivity over ion channels. Journal of Medicinal Chemistry 42(14): 2706-2715
Bloomer, J.C.; Boyd, H.F.; Hickey, D.M.; Ife, R.J.; Leach, C.A.; Macphee, C.H.; Milliner, K.J.; Pinto, I.L.; Rawlings, D.A.; Smith, S.A.; Stansfield, I.G.; Stanway, S.J.; Taylor, M.A.; Theobald, C.J.; Whittaker, C.M. 2001: 1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2). Bioorganic and Medicinal Chemistry Letters 11(14): 1925-1929
Brozinick, J., T.,. Jr.;; Reynolds, T., H.; Dean, D.; Cartee, G.; Cushman, S., W. 1999: 1-(N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl)-4-phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle. Biochemical Journal 339(3): 533-540
Webb, H.K.; Wu, Z.; Sirisoma, N.; Ha, H.C.; Casero, R.A.; Woster, P.M. 1999: 1-(N-alkylamino)-11-(N-ethylamino)-4,8-diazaundecanes: Simple synthetic polyamine analogues that differentially alter tubulin polymerization. Journal of Medicinal Chemistry 42(8): 1415-1421
Knoll, J.; Miklya, Ió.; Knoll, B.; Yasusa, T.; Shimazu, S.; Yoneda, F. 2002: 1-(benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged. Life Sciences 71(17): 1975-1984
Isaac, M.B.; Xin, T.; O'Brien, A.; St-Martin, D.; Naismith, A.; MacLean, N.; Wilson, J.; Demchyshyn, L.; Tehim, A.; Slassi, A. 2002: 1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT(7) receptor ligands. Bioorganic and Medicinal Chemistry Letters 12(17): 2451-2454
Baumann, M.H.; Ayestas, M.A.; Dersch, C.M.; Rothman, R.B. 2001: 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 24(5): 492-501
Tantry, S., J.; Babu, V., V.S.resh 2002: 1-(t-butyldimethylsilyloxy) benzotriazole (TBDMS-OBt): A new and novel reagent for the synthesis of peptides. Letters in Peptide Science 9(1): 35-41
Speciale, L.; Ruzzante, S.; Calabrese, E.; Saresella, M.; Taramelli, D.; Mariani, C.; Bava, L.; Longhi, R.; Ferrante, P. 2003: 1-40 Beta-amyloid protein fragment modulates the expression of CD44 and CD71 on the astrocytoma cell line in the presence of IL1beta and TNFalpha. Journal of Cellular Physiology 196(1): 190-195
Athenstaedt, K.; Daum, G. 2000: 1-Acyldihydroxyacetone-phosphate reductase (Ayr1p) of the yeast Saccharomyces cerevisiae encoded by the open reading frame YIL124w is a major component of lipid particles. Journal of Biological Chemistry 275(1): 235-240
Kozikowski, A.P.; Araldi, G.L.; Tückmantel, W.; Pshenichkin, S.; Surina, E.; Wroblewski, J.T. 1999: 1-Amino-APDC, a partial agonist of group II metabotropic glutamate receptors with neuroprotective properties. Bioorganic and Medicinal Chemistry Letters 9(12): 1721-1726
Kakuta, Y.; Igarashi, T.; Murakami, T.; Ito, H.; Matsui, H.; Honma, M. 2001: 1-Aminocyclopropane-1-carboxylate synthase of Penicillium citrinum: primary structure and expression in Escherichia coli and Saccharomyces cerevisiae. Bioscience Biotechnology and Biochemistry 65(7): 1511-1518
Jakubowicz, M.; Sadowski, J. 2002: 1-Aminocyclopropane-1-carboxylate synthase: Genes and expression. Acta Physiologiae Plantarum 24(4): 459-478
Chen, J.T.; Chang, W.C. 2003: 1-Aminocyclopropane-1-carboxylic acid enhanced direct somatic embryogenesis from Oncidium leaf cultures. Biologia Plantarum 46(3): 455-458
Coppola, G.M.; Zhang, Y.L.; Schuster, H.F.; Russell, M.E.; Hughes, T.E. 2000: 1-Aminomethylisoquinoline-4-carboxylates as novel dipeptidylpeptidase IV inhibitors. Bioorganic and Medicinal Chemistry Letters 10(14): 1555-1558
Matulis, D.; Baumann, C.G.; Bloomfield, V.A.; Lovrien, R.E. 1999: 1-anilino-8-naphthalene sulfonate as a protein conformational tightening agent. Biopolymers 49(6): 451-458
Mokrosz, M.J.; Duszynska, B.; Wesolowska, A.; Borycz, J.; Chojnacka-Wojcik, E.; Karolak-Wojciechowska, J. 2000: 1-Aryl-1,4-dihydro-3(2H)-isoquinolinones: Two modes of interaction with 5-HT1A receptors. Medicinal Chemistry Research 10(1): 58-68
Abd, E.Nabi, Hisham, A. 2002: 1-Aryl-5-methoxypyrrolones as synthons for fused heterocycles. Tetrahedron 58(1): 135-141, 1 January
Ukita, T.; Nakamura, Y.; Kubo, A.; Yamamoto, Y.; Takahashi, M.; Kotera, J.; Ikeo, T. 1999: 1-Arylnaphthalene lignan: a novel scaffold for type 5 phosphodiesterase inhibitor. Journal of Medicinal Chemistry 42(7): 1293-1305
Costantino, L.; Rastelli, G.; Gamberini, M.C.; Vinson, J.A.; Bose, P.; Iannone, A.; Staffieri, M.; Antolini, L.; Del Corso, A.; Mura, U.; Albasini, A. 1999: 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors. Journal of Medicinal Chemistry 42(11): 1881-1893
Shavali, S.; Ebadi, M. 2003: 1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), an endogenous neurotoxin, induces dopaminergic cell death through apoptosis. Neurotoxicology 24(3): 417-424
Delacour, D.; Gouyer, Vérie.; Leteurtre, E.; Ait-Slimane, T.; Drobecq, Hé.; Lenoir, C.; Moreau-Hannedouche, O.; Trugnan, G.; Huet, G. 2003: 1-benzyl-2-acetamido-2-deoxy-alpha-D-galactopyranoside blocks the apical biosynthetic pathway in polarized HT-29 cells. Journal of Biological Chemistry 278(39): 37799-37809
Ichihara, G.; Kitoh, J.; Yu, X.; Asaeda, N.; Iwai, H.; Kumazawa, T.; Shibata, E.; Yamada, T.; Wang, H.; Xie, Z.; Takeuchi, Y. 2000: 1-Bromopropane, an alternative to ozone layer depleting solvents, is dose-dependently neurotoxic to rats in long-term inhalation exposure. Toxicological Sciences: An Official Journal of the Society of Toxicology 55(1): 116-123
Chen, J.W.; Dodia, C.; Feinstein, S.I.; Jain, M.K.; Fisher, A.B. 2000: 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. Journal of Biological Chemistry 275(37): 28421-28427
Inaba, M. 2000: 1-Day Acuvue vs. Focus Dailies: a comparison of comfort, user preference, and incidence of corneal complications. Clao Journal: Official Publication of the Contact Lens Association of Ophthalmologists Inc 26(3): 141-145
Lozano, M.; Escolar, G.; Bellucci, S.; Monteagudo, J.; Pico, M.; Ordinas, A.; Caen, J.P. 2006: 1-Deamino (8-D-arginine) vasopressin infusion partially corrects platelet deposition on subendothelium in Bernard-Soulier syndrome: the role of factor VIII. Platelets 10(2-3): 141-145
Hahn, F.M.; Eubanks, L.M.; Testa, C.A.; Blagg, B.S.; Baker, J.A.; Poulter, C.D. 2001: 1-Deoxy-D-xylulose 5-phosphate synthase, the gene product of open reading frame (ORF) 2816 and ORF 2895 in Rhodobacter capsulatus. Journal of Bacteriology 183(1): 1-11
Fechter, M., H.; Gaisberger, R.; Griengl, H. 2001: 1-Deoxy-D-xylulose synthesized from the (S)-cyanohydrin of acrolein. Journal of Carbohydrate Chemistry 20(9): 833-839
Hamilton, K.L.; Meads, L.; Butt, A.G. 1999: 1-EBIO stimulates Cl- secretion by activating a basolateral K+ channel in the mouse jejunum. Pfluegers Archiv European Journal of Physiology 439(1-2): 158-166
Li, P.; Xu, J.C.eng 2000: 1-Ethyl 2-halopyridinium salts, highly efficient coupling reagents for hindered peptide synthesis both in solution and the solid-phase. Tetrahedron 56(41): 8119-8131, 6 October
Tsukamoto, H.; Kondo, Y. 2003: 1-Fluoropyridinium triflates: Versatile reagents for transformation of thioglycoside into O-glycoside, glycosyl azide and sulfoxide. Tetrahedron Letters 44(28): 5247-5249, 7 July
Giessing, A.M.B.; Mayer, L.M.; Forbes, T.L. 2003: 1-Hydroxypyrene glucuronide as the major aqueous pyrene metabolite in tissue and gut fluid from the marine deposit-feeding polychaete Nereis diversicolor. Environmental Toxicology and Chemistry 22(5): 1107-1114
Jacobs, C.; Frotscher, M.; Dannhardt, G.; Hartmann, R.W. 2000: 1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase and aromatase. Journal of Medicinal Chemistry 43(9): 1841-1851
Hartmann, R.W.; Frotscher, M. 1999: 1-Imidazolylcarbonyloxy-substituted tetrahydroquinolines and pyridines: Synthesis and evaluation of P450 TxA2 inhibition. Archiv der Pharmazie 332(10): 358-362
Eichler, E.; Yan, F.; Sealy, J.; Whitfield, D.M. 2001: 1-Methyl 1'-cyclopropylmethyl: An acid labile O-protecting group for polymer-supported oligosaccharide synthesis. Tetrahedron 57(31): 6679-6693, 30 July
Herraiz, T. 1999: 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid and 1,2, 3,4-tetrahydro-beta-carboline-3-carboxylic acid in fruits. Journal of Agricultural and Food Chemistry 47(12): 4883-4887
Antkiewicz-Michaluk, L.; Karolewicz, B.; Romańska, I.; Michaluk, J.; Bojarski, A.J.; Vetulani, J. 2003: 1-Methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain. European Journal of Pharmacology 466(3): 263-269
Shimoke, K.; Kudo, M. 2002: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine has a transient proliferative effect on PC12h cells and nerve growth factor additively promotes this effect: Possible involvement of distinct mechanisms of activation of MAP kinase family proteins. Brain Research. Developmental Brain Research 133(2): 105-114
Kita, T.; Saraya, T.; Konishi, N.; Matsunari, Y.; Shimada, K.; Nakamura, M.; O'hara, K.; Wagner, G.C.; Nakashima, T. 2003: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity. Pharmacology and Toxicology 92(2): 71-80
Ortiz, G.G.; Zúñiga-González, G.; García, J.ín.J.; Torres-Bugarín, O.; Zamora-Perez, A.; Bitzer-Quintero, O.K. 2003: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced lipid peroxidation and DNA damage in mouse bone marrow and blood. Environmental and Molecular Mutagenesis 41(1): 64-68
Lee, E.S.; Charlton, C.G. 2001: 1-Methyl-4-phenyl-pyridinium increases S-adenosyl-L-methionine dependent phospholipid methylation. Pharmacology Biochemistry and Behavior 70(1): 105-114
Wu, J.; Chan, P.; Schroeder, K.M.; Ellsworth, K.; Partridge, L.Donald.L. 2002: 1-Methyl-4-phenylpridinium (MPP+)-induced functional run-down of GABA(A) receptor-mediated currents in acutely dissociated dopaminergic neurons. Journal of Neurochemistry 83(1): 87-99
Kalivendi, S.V.; Kotamraju, S.; Cunningham, S.; Shang, T.; Hillard, C.J.; Kalyanaraman, B. 2003: 1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide. Biochemical Journal 371(Pt 1): 151-164
Shang, T.; Uihlein, A.V.; Van Asten, J.; Kalyanaraman, B.; Hillard, C.J. 2003: 1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3. Journal of Neurochemistry 85(2): 358-367
Luchowski, P.; Luchowska, E.; Turski, W.A.; Urbanska, E.M. 2002: 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats. Neuroscience Letters 330(1): 49-52
Miyako, K.; Irie, T.; Muta, T.; Umeda, S.; Kai, Y.; Fujiwara, T.; Takeshige, K.; Kang, D. 1999: 1-Methyl-4-phenylpyridinium ion (MPP+) selectively inhibits the replication of mitochondrial DNA. European Journal of Biochemistry 259(1-2): 412-418
Iwaasa, M.; Umeda, S.; Ohsato, T.; Takamatsu, C.; Fukuoh, A.; Iwasaki, H.; Shinagawa, H.; Hamasaki, N.; Kang, D. 2002: 1-Methyl-4-phenylpyridinium ion, a toxin that can cause parkinsonism, alters branched structures of DNA. Journal of Neurochemistry 82(1): 30-37
Mita, M.; Yoshikuni, M.; Nagahama, Y. 1999: 1-Methyladenine production from ATP by starfish ovarian follicle cells. Biochimica et Biophysica Acta 1428(1): 13-20
Heyes, J.A.; Johnston, J.W. 1998: 1-Methylcyclopropene extends Cymbidium orchid vaselife and prevents damaged pollinia from acclerating senescence. New Zealand Journal of Crop and Horticultural Science 26(4): 319-324
Gebicki, J.; Sysa-Jedrzejowska, A.; Adamus, J.; Woźniacka, A.; Rybak, Młgorzata.; Zielonka, J. 2003: 1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin. Polish Journal of Pharmacology 55(1): 109-112
Kalinowski, M.; Kress, O.; Wels, T.; Alfke, H.; Klose, K.J.; Wagner, H.-J. 2003: 1-molar gadobutrol as a contrast agent for computed tomography: results from a comparative porcine study. Investigative Radiology 38(4): 193-199
Gökhan, N.; Yeşilada, A.ül.; Uçar, G.ül.; Erol, K.; Bilgin, A.A. 2003: 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors. Archiv der Pharmazie 336(8): 362-371
Pappayee, N.; Mishra, A.K. 2000: 1-Naphthol as an excited state proton transfer fluorescent probe for erythrocyte membranes. Spectrochimica Acta. Part A Molecular and Biomolecular Spectroscopy 56a(11): 2249-2253
Inoue, H.; Yokota, H.; Taniyama, H.; Kuwahara, A.; Ogawa, H.; Kato, S.; Yuasa, A. 1999: 1-Naphthol beta-D-glucuronide formed intraluminally in rat small intestine mucosa and absorbed into the colon. Life Sciences 65(15): 1579-1588
Zinin, A.I.; Eneyskaya, E.V.; Shabalin, K.A.; Kulminskaya, A.A.; Shishlyannikov, S.M.; Neustroev, K.N. 2002: 1-O-Acetyl-beta-D-galactopyranose: a novel substrate for the transglycosylation reaction catalyzed by the beta-galactosidase from Penicillium sp. Carbohydrate Research 337(7): 635-642
Gopinath, D.; Ravi, D.; Rao, B.R.; Apte, S.S.; Rambhau, D. 2002: 1-O-Alkylglycerol vesicles (Algosomes): Their formation and characterization. International Journal of Pharmaceutics 246(1-2): 187-197
Gijsbers, S.; Asselberghs, S.; Herdewijn, P.; Van Veldhoven, P.P. 2002: 1-O-Hexadecyl-2-desoxy-2-amino-sn-glycerol, a substrate for human sphingosine kinase. Biochimica et Biophysica Acta 1580(1): 1-8
Tellis, C.; Lekka, M.E. 2000: 1-O-alkyl-2-acetyl-sn-glycero-3-phosphate:phosphohydrolase activity in Tetrahymena pyriformis. Journal of Eukaryotic Microbiology 47(2): 122-128
Cheminade, C.él.; Gautier, V.ér.; Hichami, A.; Allaume, P.; Le Lannou, D.; Legrand, A.B. 2002: 1-O-alkylglycerols improve boar sperm motility and fertility. Biology of Reproduction 66(2): 421-428
Abou-Zaid, M.; Nozzolillo, C. 1999: 1-O-galloyl-alpha-L-rhamnose from Acer rubrum. Phytochemistry 52(8): 1629-1631
Liu, W.; Itoigawa, M.; Miki, T.; Nishikawa, H.; Sugiyama, S.; Ishikawa, N. 2002: 1-O-hexyl-2,3,5-trimethylhydroquinone inhibits IkappaB phosphorylation and degradation-linked inducible nitric oxide synthase expression: beyond antioxidant function. Journal of Pharmacy and Pharmacology 54(3): 383-389
Lützhøft, H.C.; Vaes, W.H.; Freidig, A.P.; Halling-Sørensen, B.; Hermens, J.L. 2000: 1-octanol/water distribution coefficient of oxolinic acid: influence of pH and its relation to the interaction with dissolved organic carbon. Chemosphere 40(7): 711-714
Aoyama, Y.; Uenaka, M.; Konoike, T.; Iso, Y.; Nishitani, Y.; Kanda, A.; Naya, N.; Nakajima, M. 2000: 1-Oxacephem-based human chymase inhibitors: Discovery of stable inhibitors in human plasma. Bioorganic and Medicinal Chemistry Letters 10(21): 2403-2406
Magiatis, P.; Mitaku, S.; Skaltsounis, A.L.; Tillequin, F. 2001: 1-Oxo-2-hydroxy-1,2-dihydroacronycine: a useful synthon in the acronycine series for the introduction of amino substituents at 6-position and for the conversion into isopropylfuroacridones. Chemical and Pharmaceutical Bulletin 49(10): 1304-1307
Bucholtz, E., C.; Wyrick, S., D.; Owens, C., E.; Mcphail, A., T.; Booth, M., G. 1998: 1-Phenyl-3-dimethylamino-1,2,3,4-tetrahydronaphthalene (H2-PAT): Effect of stereochemistry on binding and function at brain histamine receptors. Medicinal Chemistry Research 8(6): 322-332
Dumas, J.; Hatoum-Mokdad, H.; Sibley, R.; Riedl, B.; Scott, W.J.; Monahan, M.K.; Lowinger, T.B.; Brennan, C.; Natero, R.; Turner, T.; Johnson, J.S.; Schoenleber, R.; Bhargava, A.; Wilhelm, S.M.; Housley, T.J.; Ranges, G.E.; Shrikhande, A. 2000: 1-Phenyl-5-pyrazolyl ureas: Potent and selective p38 kinase inhibitors. Bioorganic and Medicinal Chemistry Letters 10(18): 2051-2054
Corriere, J.N. 2001: 1-Stage delayed bulboprostatic anastomotic repair of posterior urethral rupture: 60 patients with 1-year followup. Journal of Urology 165(2): 404-407
Bukkapatnam, R.; Seigne, J.; Helal, M. 2003: 1-step removal of encrusted retained ureteral stents. Journal of Urology 170(4 Part 1): 1111-1114
Gerlach, M.; Xiao, A.Y.; Heim, C.; Lan, J.; God, R.; Feineis, D.; Bringmann, G.; Riederer, P.; Sontag, K.H. 1998: 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats. Neuroscience Letters 257(1): 17-20
Verevka, S.V.; Miroshnychenko, O.S. 2001: 1-X-3 motif in inter-protein recognition: structures, widespreading and possible practical application. Journal of Molecular Recognition: Jmr 14(5): 315-318
Gérard, Séphane.; Nollet, Gëtan.; Vande Put, J.; Marchand-Brynaert, J. 2002: 1-alkoxycarbonyl-3-halogenoazetidin-2-ones as elastase (PPE) inhibitors. Bioorganic and Medicinal Chemistry 10(12): 3955-3964
Rewinkel, J.B.; Lucas, H.; van Galen, P.J.; Noach, A.B.; van Dinther, T.G.; Rood, A.M.; Jenneboer, A.J.; van Boeckel, C.A. 1999: 1-aminoisoquinoline as benzamidine isoster in the design and synthesis of orally active thrombin inhibitors. Bioorganic and Medicinal Chemistry Letters 9(5): 685-690
Eiermann, B.; Edlund, P.O.; Tjernberg, A.; Dalén, P.; Dahl, M.L.; Bertilsson, L. 1998: 1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humans. Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(11): 1096-1101
Patil, N.T.; John, S.; Sabharwal, S.G.; Dhavale, D.D. 2002: 1-aza-sugars from D-glucose. Preparation of 1-deoxy-5-dehydroxymethyl-nojirimycin, its analogues and evaluation of glycosidase inhibitory activity. Bioorganic and Medicinal Chemistry 10(7): 2155-2160
Lien, J-Cherng.; Lee, F-Yu.; Huang, L-Jiau.; Pan, S-Lin.; Guh, J-Hwa.; Teng, C-Ming.; Kuo, S-Chu. 2002: 1-Benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole (YC-1) derivatives as novel inhibitors against sodium nitroprusside-induced apoptosis. Journal of Medicinal Chemistry 45(23): 4947-4949
Bajramovic, J.J.; Syan, S.; Brahic, M.; de la Torre, J.Carlos.; Gonzalez-Dunia, D. 2002: 1-beta-D-arabinofuranosylcytosine inhibits borna disease virus replication and spread. Journal of Virology 76(12): 6268-6276
Yamauchi, T.; Kawai, Y.; Ueda, T. 2002: 1-beta-D-arabinofuranosylcytosine is cytotoxic in quiescent normal lymphocytes undergoing DNA excision repair. Japanese Journal of Cancer Research: Gann 93(12): 1334-1341
Adeagbo, A.S. 1999: 1-Ethyl-2-benzimidazolinone stimulates endothelial K(Ca) channels and nitric oxide formation in rat mesenteric vessels. European Journal of Pharmacology 379(2-3): 151-159
Mukherjee, S.; Rodrigues, E.; Weker, R.; Palmer, L.J.; Christiani, D.C. 2002: 1-hydroxypyrene as a biomarker of occupational exposure to polycyclic aromatic hydrocarbons (PAH) in boilermakers. Journal of Occupational and Environmental Medicine 44(12): 1119-1125
Huffman, J.W.; Bushell, S.M.; Miller, J.R.A.; Wiley, J.L.; Martin, B.R. 2002: 1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptor. Bioorganic and Medicinal Chemistry 10(12): 4119-4129
Shi, H.; Noguchi, N.; Xu, Y.; Niki, E. 1999: 1-methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium. FEBS Letters 461(3): 196-200
Leist, M.; Volbracht, C.; Fava, E.; Nicotera, P. 1998: 1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis. Molecular Pharmacology 54(5): 789-801
Storch, A.; Kaftan, A.; Burkhardt, K.; Schwarz, J. 2000: 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Research 855(1): 67-75
Ku, V.V.V.; Wills, R.B.H.; Ben Yehoshua, S. 1999: 1-methylcyclopropene can differentially affect the postharvest life of strawberries exposed to ethylene. HortScience 34(1): 119-120
Tsuneoka, M.; Mekada, E. 1998: 1-myc transactivates RCC1 genes expression in rat fibroblast cells transformed by N-myc and v-ras. Journal of Biochemistry (Tokyo) 124(5): 1013-1019
Ember, I.; Pusztai, Z.; Gyöngyi, Z.; Kiss, I. 2000: 1-Nitropyrene induces elevated expression of oncogenes and tumor suppressor genes 24 hours after treatment in CBA/Ca mice. Anticancer Research 20(3a): 1563-1566
Farkas, A.; Chertin, B.; Hadas-Halpren, I. 2001: 1-stage feminizing genitoplasty: 8 years of experience with 49 cases. Journal of Urology 165(6 Pt 2): 2341-2346
Bringmann, G.; Feineis, D.; God, R.; Peters, K.; Peters, E-Maria.; Scholz, J.; Riederer, F.; Moser, A. 2002: 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) and related derivatives: chemistry and biochemical effects on catecholamine biosynthesis. Bioorganic and Medicinal Chemistry 10(7): 2207-2214
Kakko, J.; Svanborg, K.Dybrandt.; Kreek, M.Jeanne.; Heilig, M. 2003: 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet 361(9358): 662-668
Acar, N.; Patterson, P.H.; Barbato, G.F. 2001: 1. Appetite suppressant activity of supplemental dietary amino acids and subsequent compensatory growth of broilers. Poultry Science 80(8): 1215-1222
Eng, H.M.; Myles, D.C. 1999: 1. Synthesis of the common C.1-C.13 hydrophobic domain of the B-type amphidinolides. Tetrahedron Letters 40(12): 2275-2278
Kostel, Jill, A.; Wang, Hong; St-Amand, Ann, L.; Gray, Kimberly, A. 1999: 1. Use of a novel laboratory stream system to study the ecological impact of PCB exposure in a periphytic biolayer. Water Research 33(18): 3735-3748
Boltes, I.; Czapinska, H.; Kahnert, A.; von Bülow, R.; Dierks, T.; Schmidt, B.; von Figura, K.; Kertesz, M.A.; Usón, I. 2001: 1.3 A structure of arylsulfatase from Pseudomonas aeruginosa establishes the catalytic mechanism of sulfate ester cleavage in the sulfatase family. Structure 9(6): 483-491
Essen, L-Oliver.; Harrenga, A.; Ostermeier, C.; Michel, H. 2003: 1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization. Acta Crystallographica. Section D Biological Crystallography 59(Pt 4): 677-687
Ramirez, M.I.; Cao, Y.X.; Williams, M.C. 1999: 1.3 kilobases of the lung type i cell T1alpha gene promoter mimics endogenous gene expression patterns during development but lacks sequences to enhance expression in perinatal and adult lung. Developmental Dynamics: An Official Publication of the American Association of Anatomists 215(4): 319-331
Kresge, N.; Vacquier, V.D.; Stout, C.D. 2000: 1.35 and 2.07 A resolution structures of the red abalone sperm lysin monomer and dimer reveal features involved in receptor binding. Acta Crystallographica. Section D Biological Crystallography 56(Pt 1): 34-41
Knight, S.W.; Vulliamy, T.J.; Heiss, N.S.; Matthijs, G.; Devriendt, K.; Connor, J.M.; D'Urso, M.; Poustka, A.; Mason, P.J.; Dokal, I. 1998: 1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis. Journal of Medical Genetics 35(12): 993-996
van Santen, Y.; Benen, J.A.; Schröter, K.H.; Kalk, K.H.; Armand, S.; Visser, J.; Dijkstra, B.W. 1999: 1.68-A crystal structure of endopolygalacturonase II from Aspergillus niger and identification of active site residues by site-directed mutagenesis. Journal of Biological Chemistry 274(43): 30474-30480
Usón, I.; Pohl, E.; Schneider, T.R.; Dauter, Z.; Schmidt, A.; Fritz, H.J.; Sheldrick, G.M. 1999: 1.7 A structure of the stabilized REIv mutant T39K. Application of local NCS restraints. Acta Crystallographica. Section D Biological Crystallography 55(Pt 6): 1158-1167
Wohlfahrt, G.; Witt, S.; Hendle, J.; Schomburg, D.; Kalisz, H.M.; Hecht, H.J. 1999: 1.8 and 1.9 A resolution structures of the Penicillium amagasakiense and Aspergillus niger glucose oxidases as a basis for modelling substrate complexes. Acta Crystallographica. Section D Biological Crystallography 55(Pt 5): 969-977
Shi, D.; Morizono, H.; Ha, Y.; Aoyagi, M.; Tuchman, M.; Allewell, N.M. 1998: 1.85-A resolution crystal structure of human ornithine transcarbamoylase complexed with N-phosphonacetyl-L-ornithine. Catalytic mechanism and correlation with inherited deficiency. Journal of Biological Chemistry 273(51): 34247-34254
Pillai, B.; Kannan, K.K.; Hosur, M.V. 2001: 1.9 A x-ray study shows closed flap conformation in crystals of tethered HIV-1 PR. Proteins 43(1): 57-64
Perler, L.; Heim, D.; Geiser, F.; Mueller, H.K.; Kihm, U. 2000: Ten years of BSE in Switzerland. The development of an extraordinary disease. Schweizer Archiv für Tierheilkunde 142(12): 657-664
Clerici, T.; Schmid, C.; Komminoth, P.; Lange, J.; Spinas, G.A.; Brändle, M. 2001: 10 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods. Swiss Medical Weekly 131(25-26): 381-386
Hickey, R.W.; Zhu, R.L.; Alexander, H.L.; Jin, K.L.; Stetler, R.A.; Chen, J.; Kochanek, P.M.; Graham, S.H. 2000: 10 kD mitochondrial matrix heat shock protein mRNA is induced following global brain ischemia in the rat. Brain Research. Molecular Brain Research 79(1-2): 169-173
Richardson, K. 1998: 10 years of Wadden and North Sea protection: Evaluation and perspectives. Senckenbergiana Maritima 29(1-6): 7-11
Chiang, H.S.; Wu, C.C.; Wen, T.C. 2000: 10 years of experience with penile prosthesis implantation in Taiwanese patients. Journal of Urology 163(2): 476-480
Dragani, T.A. 2003: 10 years of mouse cancer modifier loci: human relevance. Cancer research 63(12): 3011-3018
Silber, S. 2000: 10 years of vascular closure devices: A critical analysis of their usefulness after PTCA. Zeitschrift fuer Kardiologie 89(5): 383-389
Rabinerson, D.; Ben Rafael, Z.; Keslin, J.; Zolotarsky, V.; Dekel, A. 2001: 10% hydroxyethyl starch for plasma expansion in the treatment of severe ovarian hyperstimulation syndrome. A case report. Journal of Reproductive Medicine 46(1): 68-70
Kim, H.; Gardner, H., W.; Hou, C., T. 2000: 10(S)-hydroxy-8(E)-octadecenoic acid, an intermediate in the conversion of oleic acid to 7,10-dihydroxy-8(E)-octadecenoic acid. Journal of the American Oil Chemists' Society 77(1): 95-99
Marsilje, T.H.; Hedrick, M.P.; Desharnais, J.; Capps, K.; Tavassoli, A.; Zhang, Y.; Wilson, I.A.; Benkovic, S.J.; Boger, D.L. 2003: 10-(2-Benzoxazolcarbonyl)-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid: A potential inhibitor of GAR transformylase and AICAR transformylase. Bioorganic and Medicinal Chemistry 11(20): 4503-4509
Herzel, H.; Weiss, O.; Trifonov, E.N. 1999: 10-11 bp periodicities in complete genomes reflect protein structure and DNA folding. Bioinformatics 15(3): 187-193
Marsilje, T.H.; Labroli, M.A.; Hedrick, M.P.; Jin, Q.; Desharnais, J.; Baker, S.J.; Gooljarsingh, L.T.; Ramcharan, J.; Tavassoli, A.; Zhang, Y.; Wilson, I.A.; Beardsley, G.Peter.; Benkovic, S.J.; Boger, D.L. 2002: 10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): A potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway. Bioorganic and Medicinal Chemistry 10(8): 2739-2749
Onsrud, M.; Hagen, B.; Strickert, T. 2001: 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri. Gynecologic Oncology 82(1): 167-171
Claridge, T.D.W.; Goodman, J.M.; Moreno, A.; Angus, D.; Barker, S.F.; Taillefumier, C.; Watterson, M.P.; Fleet, G.W.J. 2001: 10-Helical conformations in oxetane beta-amino acid hexamers. Tetrahedron Letters 42(25): 4251-4255, 18 June
Mueller, K.; Reindl, H.; Gawlik, I. 1998: 10-Hydrocinnamoyl-and 10-cinnamoyl-1,8-dihydroxy-9(10H)-anthracenones as inhibitors of leukotriene B4 biosynthesis and HaCaT cell growth. European Journal of Medicinal Chemistry 33(12): 969-973
Proksa, B. 1999: 10-Hydroxythebaine. Archiv der Pharmazie (Weinheim) 332(10): 369-370
Hinrichs, F.; Boudriot, U.; Held, T.; Griss, P. 2001: 10-Jahres-Ergebnisse einer Monobloc-Hueftendoprothesenpfanne mit mehrlagiger Reintitangitterschale zur zementfreien Implantation. Zeitschrift fuer Orthopaedie und ihre Grenzgebiete 139(3): 212-216
Jaeger, A.; Welsch, F.; Braune, C.; Eberhardt, C.; Kappler, C. 2003: 10-Jahres-Ergebnisse nach arthroskopischer vorderer Kreuzbandrekonstruktion mit dem Patellarsehnen-transplantat. Zeitschrift fuer Orthopaedie und ihre Grenzgebiete 141(1): 42-47
Currie, G., P.; Gray, R., D.; Mckay, J. 2003: 10-Minute consultation: Chronic cough. BMJ 326(7383): 261
Samanta, J.; Kendall, J.; Samanta, A. 2003: 10-minute consultation: chronic low back pain. BMJ 326(7388): 535
Jankowski, J.; Jones, R.; Delaney, B.; Dent, J. 2002: 10-minute consultation: Gastro-oesophageal reflux disease. Bmj 325(7370): 945
A'Court, C. 2002: 10-minute consultation. Newly diagnosed hypertension. Bmj 324(7350): 1375
Pal, B. 2002: 10-minute consultation: Paraesthesia. Bmj 324(7352): 1501
Samanta, J.; Kendall, J.; Samanta, A. 2003: 10-Minute consultation: Polyarthralgia. BMJ 326(7394): 859
Kosugi, D.; Ishida, H.; Fujita, K. 2003: 10-Month-old infants' inference of invisible agent: Distinction in causality between object motion and human action. Japanese Psychological Research 45(1): 15-24
Lenart, J.; Pikuła, S. 1999: 10-Undecynoic acid, an inhibitor of cytochrome P450 4A1, inhibits ethanolamine-specific phospholipid base exchange reaction in rat liver microsomes. Acta Biochimica Polonica 46(1): 203-210
Brown, R.; Chaloner, E.; Mannion, S.; Cheatle, T. 2001: 10-year experience of injuries sustained during clearance of anti-personnel mines. Lancet 358(9298): 2048-2049
Grampsas, S.A.; Moore, M.; Chandhoke, P.S. 2000: 10-Year experience with extracorporeal shockwave lithotripsy in the state of Colorado. Journal of Endourology 14(9): 711-714
Müller, K.; Breu, K. 1999: 10-alpha-Aminoacyl-9(10H)-anthracenones: inhibition of 12(S)-HETE biosynthesis and HaCaT cell growth. Archiv der Pharmazie 332(1): 31-35
Mizuno, Y.; Nasuno, T.; Okusa, S.; Shimoda, M.; Kokue, E. 2000: 10-formyltetrahydrofolate exists in pig plasma. Nutrition Research 20(9): 1355-1359
Park, H.J.; Lim, Y.H.; Kim, Y.S.; Kyung, K.H. 1999: 10-hydroxyoctadecanoic acid produced by Lactococcus lactis subsp. lactis as a part of flocculent aggregate. Journal of Microbiology and Biotechnology 9(1): 39-43
Sheikh, A.; Walker, S. 2002: 10-minute consultation: Food allergy. BMJ 325(7376): 1337
Harnden, A.; Shakespeare, J. 2001: 10-minute consultation: MMR immunisation. Bmj 323(7303): 32
Farmer, A. 2001: 10-minute consultation: Prostatic symptoms. Bmj 322(7300): 1468
Aung, T.; Mulley, G.P. 2002: 10-minute consultation: Removal of ear wax. BMJ 325(7354): 27
McCombe, A. 2002: 10-minute consultation: rhinitis. Article is unhelpful. Bmj 324(7347): 1219
Brookes, N.; Saleh, H.; Mackay, I. 2002: 10-minute consultation: rhinitis. Referral to specialist otolaryngologist may be advisable. Bmj 324(7347): 1219
Müller, K.; Breu, K.; Reindl, H. 2001: 10-Phenylbutyryl-substituted anthracenones as inhibitors of keratinocyte growth and LTB(4) biosynthesis. European Journal of Medicinal Chemistry 36(2): 179-184
Grimm, P.D.; Blasko, J.C.; Sylvester, J.E.; Meier, R.M.; Cavanagh, W. 2001: 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. International Journal of Radiation Oncology Biology Physics 51(1): 31-40
Castera, R.; Podestá, M.L.; Ruarte, A.; Herrera, M.; Medel, R. 2001: 10-year experience with artificial urinary sphincter in children and adolescents. Journal of Urology 165(6 Pt 2): 2373-2376
Mimura, T.; Amano, S.; Sugiura, T.; Funatsu, H.; Yamagami, S.; Oshika, T.; Araie, M.; Eguchi, S. 2003: 10-year follow-up study of secondary transscleral ciliary sulcus fixated posterior chamber intraocular lenses. American Journal of Ophthalmology 136(5): 931-933
Liljegren, G.; Holmberg, L.; Bergh, J.; Lindgren, A.; Tabár, L.; Nordgren, H.; Adami, H.O. 1999: 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 17(8): 2326-2333
Zhang, Y. 2003: 100 Years of Pb deposition and transport in soils in Champaign, Illinois, U.S.A. Water Air and Soil Pollution 146(1-4): 197-210
Spinner, R.J.; Al-Rodhan, N.R.; Piepgras, D.G. 2001: 100 years of neurological surgery at the Mayo Clinic. Neurosurgery 49(2): 438-446
Koppenol, W.H. 2001: 100 years of peroxynitrite chemistry and 11 years of peroxynitrite biochemistry. Redox report: communications in free radical research 6(6): 339-341
Fee, E.; Brown, T.M. 2002: 100 years of the Pan American Health Organization. American journal of public health 92(12): 1888-1889
El Bouhmadi, A.; Laffargue, F.; Raspal, N.; Brun, J.F. 2000: 100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives. Clinical Hemorheology and Microcirculation 22(2): 99-106
Novacek, M.J. 1999: 100 million years of land vertebrate evolution: The Cretaceous-early tertiary transition. Annals of the Missouri Botanical Garden 86(2): 230-258
Steinberg, H.; Kuenstler, U. 2000: 100 years of Gustav Wilhelm Stoerring's Lectures on Psychopathology: A review of the psychiatrist's and philosopher's early years. Fortschritte der Neurologie Psychiatrie 68(6): 243-249
Victora, C.G. 2002: 100 years of PAHO: a personal testimony. American journal of public health 92(12): 1887-1888
Reshetnikova, N.M.; Kuptsov, S.V. 2002: 100-Yeas dynamics of vascular plant flora in Glubokoe Lake, Moscow district. Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody, Otdel Biologicheskii 107(5): 45-56
Plogmann, H.-Huster; Rehazek, A. 1999: 1000 Years (6th to 16th century) of economic life in the heart of Europe. Common and distinct trends in cattle economy of the Baltic Sea region and the Swiss region of the Alpine Forelands. Archaeofauna 8: 123-133
He, L.; Li, T.; Melville, C.; Liu, S.; Feng, G.Y.; Gu, N.F.; Fox, H.; Shaw, D.; Breen, G.; Liu, X.; Sham, P.; Brown, J.; Collier, D.; St Clair, D. 1999: 102T/C polymorphism of serotonin receptor type 2A gene is not associated with schizophrenia in either Chinese or British populations. American Journal of Medical Genetics 88(1): 95-98
Guevara-Chumacero, L.M.; Lopez-Wilchis, R.; Sanchez-Cordero, V. 2001: 105 anos de investigacion mastozoologica en Mexico (1890-1995): una revision de sus enfoques y tendencias*. Acta Zoologica Mexicana 83: 35-72
McNeill, F.E.; Stokes, L.; Brito, J.A.; Chettle, D.R.; Kaye, W.E. 2000: 109Cd K x ray fluorescence measurements of tibial lead content in young adults exposed to lead in early childhood. Occupational and Environmental Medicine 57(7): 465-471
Hunder, G.; Javdani, J.; Elsenhans, B.; Schümann, K. 2001: 109Cd accumulation in the calcified parts of rat bones. Toxicology 159(1-2): 1-10
Takeda, A.; Takefuta, S.; Ijiro, H.; Okada, S.; Oku, N. 1999: 109Cd transport in rat brain. Brain Research Bulletin 49(6): 453-457